Category: Health

  • MIL-OSI USA: School of Nursing Class of 2029 Student Profiles: Abigail Griffiths and Katherine Wojtas

    Source: US State of Connecticut

    As summer continues, so does orientation. With over 200 students entering the School of Nursing as the class of 2029, the program’s academic advisors make sure every student is equipped with the necessary tools to succeed.

    These students all have a different story to tell, but no matter their journey they all have one thing in common – a passion for nursing.

    Abigail Griffiths (Contributed Photo)

    Abigail (Abby) Griffiths

    From Northeast Ohio, Abigail Griffiths ’29 (NURS) wants nothing more than to be a pediatric oncology nurse. Her experience with friends and family having cancer is what motivates her to be that helping hand when times get tough.

    When Griffiths was younger, her grandmother passed away from cancer, leaving a lasting impact on Griffiths’ life. She also witnessed the effects cancer had on one of her friends from her high school tennis team. Griffiths saw the mental and physical struggles her teammate and grandmother were dealing with and knew how hard that battle had been.

    “To be able to be someone who can help people who are going through similar situations is really important to me,” said Griffiths. “So being able to hopefully make a difference in someone’s life or even being able to make someone smile when they are sick or having a rough time makes me happy and is something I strive to do.”

    The research opportunities that the School of Nursing offers, and UConn’s community and environment is what stood out to Griffiths when choosing where to continue her education.

    Griffiths referred to UConn as “one big family,” and while she’s excited to further her education in nursing, she is also ready to discover herself. During her time as a Husky, she plans on continuing her swimming career by joining UConn Club Swimming. She’s also looking forward to UConn basketball games and meeting new people within her School of Nursing class.

    As she gets ready to become a Husky this fall semester, she’s taking a special piece of advice from her swimming coach with her: “You are just as worthy and capable of everything in life just as much as everyone else – I deserve to be here and I am capable of doing very well in nursing school and even through hard times I can still do great things,” Griffiths said.

    Katherine Wojtas (Contributed Photo)

    Katherine (Katie) Wojtas

    Katherine Wojtas ’29 (NURS), from upstate New York, is no stranger when it comes to traveling. Wojtas has been to the Dominican Republic three times to assist in community development and sustainability projects and doesn’t plan on stopping there.

    While in the Dominican Republic she helped communities in the sugar cane fields. With her fellow students, she laid cement floors in houses, built a running water system, and built latrines. Wojtas plans to continue doing community service abroad as a Husky, where she can hopefully travel with the School of Nursing.

    “The opportunities for local and global service were one of the main reasons why I chose UConn,” she said. “I hope to travel to Ireland or Rwanda with the School of Nursing since it is a meaningful way to learn and make an impact at the same time!”

    Wojtas is entering her first year with experience in the healthcare field. During her senior year of high school, she participated in a medical career program at her local nursing home. She received hands-on experience in various healthcare roles and got to shadow nurses.

    “It helped me confirm my passion for nursing by allowing me to shadow professionals and learn basic clinical skills. It also opened my eyes to the impact nurses have on patient care,” she said.

    Her goal is to become a nurse practitioner and in the future work as a dermatologist or obstetrician-gynecologist (OBGYN). She’s excited to start clinicals and learn from the School of Nursing faculty.

    Apart from her own academics and studying abroad, Wojtas wants to join the Women’s Club Flag Football team and healthcare affiliated clubs to connect with others who have similar interests.

    “I hope to grow personally and professionally, maintain strong grades, and gain the confidence and skills necessary to become an RN,” said Wojtas.

    Check out our other class of 2029 student profiles:

    Shaunty Mae Vidad and Carlin Sabo

    MIL OSI USA News

  • MIL-OSI United Kingdom: Regeneration of 291 Harrow Road secures planning consent | Westminster City Council

    Source: City of Westminster

    • Westminster City Council’s 291 Harrow Road development secured planning approval from the planning committee last night (Tuesday July 8th).
    • 144 new homes will be developed in the centre of London. Of these, 50% will be affordable or for Adult Social Care at social rent, with the remaining homes available for the market.
    • The development will comprise three buildings at 15, 10 and five storeys in height and will embrace passive principles in design, creating a highly efficient, low-carbon scheme.
    • Those principles will help to achieve a 70% sitewide carbon reduction over the baseline.
    • The site was part of the former Harrow Road wing of St Mary’s Hospital prior to its redevelopment in the 1980s.

    The latest housing development from Westminster City Council received approval from planning committee last night, the latest phase in the creation of more than 100 new homes.  

    Across three separate buildings, the 291 Harrow Road development will deliver 144 homes with 50% affordable housing. A total of 48 will be affordable homes, 24 will be Adult Social Care units at social rent and 72 homes will be available for private sale.

    The site was part of the former Harrow Road wing of St Mary’s Hospital prior to a period of redevelopment in the 1980s.

    At the Westminster City Council planning committee on July 8, the development secured approval by three votes to two. 

    Cllr Ellie Ormsby, Westminster City Council Cabinet Member for Regeneration and Renters, said:

     “291 Harrow Road presents a fantastic opportunity for us to deliver a greater number of high-quality homes for social rent – a necessary step considering there are over 6,000 households on Westminster’s housing waiting list – while also delivering on our ambitious sustainability commitments as one of the capital’s greenest developments. 

    “Moreover, a large proportion of these homes, a sixth of the total number, are allocated for use by adult social care services, where we are seeing growing demand. We’re excited to develop a building which embraces inclusivity and delivers for the diverse needs across our community.”

    Designs for 291 Harrow Road embrace the ‘Be Lean, Clean, Green and Seen’ energy hierarchy which utilises a fabric first approach to maximise reduction in energy through passive design measures. New, high efficiency servicing equipment and efficient façades will minimise the energy usage of the building.

    The scheme will make use of air source heat pumps and solar photo photovoltaic panels to maximise the use of renewable energy. It is anticipated that across the site build, and once occupied, 291 Harrow Road will achieve a 70% sitewide reduction over the baseline for the proposed development, far exceeding the Greater London Authority target of 35%.

    Westminster City Council has committed to 50% affordable housing across its development projects, made up of social rent and London Living Rent.

    MIL OSI United Kingdom

  • MIL-OSI USA: Governor Newsom deploys firefighter strike team to support Oregon wildfire response

    Source: US State of California 2

    Jul 8, 2025

    SACRAMENTO — As wildfire conditions intensify across the Pacific Northwest, Governor Newsom has directed the deployment of a CAL FIRE Type 3 engine strike team to assist firefighting efforts in southern Oregon. The deployment includes five fire engines and a strike team leader who will join suppression operations just north of the California–Oregon border.

    “Just as Oregon supported our state during the Los Angeles firestorms, we’re glad to support our Northern neighbors with strike teams and fire engines to aid in their wildfire response efforts. I’m proud California can lend a helping hand to fellow Americans in their time of need.” 

    Governor Gavin Newsom

    CAL FIRE engines being sent to support wildfire suppression in Oregon

    This mobilization comes in response to a significant lightning event that ignited numerous wildfires across the region. Southern Oregon has experienced more than 2,000 lightning strikes in recent days, compounded by high temperatures and gusty winds. The National Weather Service has issued Red Flag Warnings through July 8 for much of southern and central Oregon, signaling elevated fire danger and the need for immediate firefighting reinforcements.

    Upon arrival in Medford, CAL FIRE resources will seamlessly integrate into Oregon’s Department of Forestry command structure to support suppression efforts on active fires. This response is part of a long-standing interstate mutual aid agreement that strengthens wildfire readiness across the western United States.

    California remains prepared to send additional resources should conditions escalate.

    “We stand with Oregon during this critical time, just as they’ve stood with us during some of California’s toughest fire seasons,” said Anale Burlew, Chief Deputy Director of CAL FIRE. “These mutual aid partnerships are built on trust, coordination, and a shared commitment to public safety.”

    Press releases, Recent news

    Recent news

    News What you need to know: The $101 million being made available today will support the development of affordable multifamily rental housing in Los Angeles, prioritizing the needs of displaced residents in the fire-devastated regions. Los Angeles, California – Six…

    News SACRAMENTO – Governor Gavin Newsom today announced the deployment of an additional 18 highly skilled Urban Search and Rescue Team members to Texas to assist with ongoing response efforts related to severe flooding impacts.The deployment includes a total of four…

    News Perris, California — On June 18, 2025, the First Partner visited the Inland Empire to meet with California communities impacted by the Trump Administration’s federal immigration raids. The First Partner visited TODEC, a local nonprofit organization that’s become…

    Jul 8, 2025

    What you need to know: The passage of Proposition 1 by California voters adds rocket fuel to Governor Gavin Newsom’s transformational overhaul of the state’s behavioral health system. These reforms refocus existing funds to prioritize Californians with the most serious mental health and substance use issues, who are too often experiencing homelessness. They also fund more than 11,150 new behavioral health beds and supportive housing units and 26,700 outpatient treatment slots.

    Los Angeles, California – California took a major step forward in correcting the damage from 50 years of neglect to the state’s mental health system with the passage of Proposition 1. This historic measure — a signature priority of Governor Gavin Newsom — adds rocket fuel to California’s overhaul of the state’s behavioral health systems. It provides a full range of mental health and substance abuse care, with new accountability metrics to ensure local governments deliver for their communities.

    This is the biggest reform of the California mental health system in decades and will finally equip partners to deliver the results all Californians need and deserve. Treatment centers will prioritize mental health and substance use support in the community like never before. Now, it’s time to roll up our sleeves and begin implementing this critical reform – working closely with city and county leaders to ensure we see results.

    Governor Gavin Newsom

    newsom-news-template
    IMG_3682-min
    contact-governor-landing
    workers-FxAJ5fkakAAtVI3
    priorities-and-progress-image
    economy-F-isBKpbsAAxdab
    gun-violence-San Diego Guns Package 2.18.22_2

    What they’re saying: 

    • Sacramento Mayor Darrell Steinberg, original author of the Mental Health Services Act: “Twenty years ago, I never could have dreamed that we would have the strong leadership we have today, committing billions and making courageous policy changes that question the conventional wisdom on mental health. Now, with the passage of Proposition 1. California is delivering on decades old promises to help people living with brain-based illnesses, to live better lives, to live independently and to live with dignity in our communities. This is a historic moment and the hard work is ahead of us.“
    • Senator Susan Eggman (D-Stockton), author of Senate Bill 326: “Today marks a day of hope for thousands of Californians who are struggling with mental illness – many of whom are living unhoused. I am tremendously grateful to my fellow Californian’s for passing this important measure.  And I am very appreciative of this Governor’s leadership to transform our behavioral health care system!”
    • Assemblymember Jacqui Irwin (D-Thousand Oaks), author of Assembly Bill 531: “This started as an audacious proposal to address the root cause of homelessness and today, Californians can be proud to know that they did the right thing by passing Proposition 1. Now, it’s time for all of us to get to work, and make sure these reforms are implemented and that we see results.”

    Bigger picture: Transforming the Mental Health Services Act into the Behavioral Health Services Act and building more community mental health treatment sites and supportive housing is the last main pillar of Governor Newsom’s Mental Health Movement – pulling together significant recent reforms like 988 crisis line, CalHOPE, CARE Court, conservatorship reform, CalAIM behavioral health expansion (including mobile crisis care and telehealth), Medi-Cal expansion to all low-income Californians, Children and Youth Behavioral Health Initiative (including expanding services in schools and on-line), Older Adult Behavioral Health Initiative, Veterans Mental Health Initiative, Behavioral Health Community Infrastructure Program, Behavioral Health Bridge Housing, Health Care Workforce for All and more.

    More details on next step here

    Press releases, Recent news

    Recent news

    News What you need to know: The $101 million being made available today will support the development of affordable multifamily rental housing in Los Angeles, prioritizing the needs of displaced residents in the fire-devastated regions. Los Angeles, California – Six…

    News SACRAMENTO – Governor Gavin Newsom today announced the deployment of an additional 18 highly skilled Urban Search and Rescue Team members to Texas to assist with ongoing response efforts related to severe flooding impacts.The deployment includes a total of four…

    News Perris, California — On June 18, 2025, the First Partner visited the Inland Empire to meet with California communities impacted by the Trump Administration’s federal immigration raids. The First Partner visited TODEC, a local nonprofit organization that’s become…

    Jul 8, 2025

    What you need to know: The passage of Proposition 1 by California voters adds rocket fuel to Governor Gavin Newsom’s transformational overhaul of the state’s behavioral health system. These reforms refocus existing funds to prioritize Californians with the most serious mental health and substance use issues, who are too often experiencing homelessness. They also fund more than 11,150 new behavioral health beds and supportive housing units and 26,700 outpatient treatment slots.

    Los Angeles, California – California took a major step forward in correcting the damage from 50 years of neglect to the state’s mental health system with the passage of Proposition 1. This historic measure — a signature priority of Governor Gavin Newsom — adds rocket fuel to California’s overhaul of the state’s behavioral health systems. It provides a full range of mental health and substance abuse care, with new accountability metrics to ensure local governments deliver for their communities.

    This is the biggest reform of the California mental health system in decades and will finally equip partners to deliver the results all Californians need and deserve. Treatment centers will prioritize mental health and substance use support in the community like never before. Now, it’s time to roll up our sleeves and begin implementing this critical reform – working closely with city and county leaders to ensure we see results.

    Governor Gavin Newsom

    newsom-news-template
    IMG_3682-min
    contact-governor-landing
    workers-FxAJ5fkakAAtVI3
    priorities-and-progress-image
    economy-F-isBKpbsAAxdab
    gun-violence-San Diego Guns Package 2.18.22_2

    What they’re saying: 

    • Sacramento Mayor Darrell Steinberg, original author of the Mental Health Services Act: “Twenty years ago, I never could have dreamed that we would have the strong leadership we have today, committing billions and making courageous policy changes that question the conventional wisdom on mental health. Now, with the passage of Proposition 1. California is delivering on decades old promises to help people living with brain-based illnesses, to live better lives, to live independently and to live with dignity in our communities. This is a historic moment and the hard work is ahead of us.“
    • Senator Susan Eggman (D-Stockton), author of Senate Bill 326: “Today marks a day of hope for thousands of Californians who are struggling with mental illness – many of whom are living unhoused. I am tremendously grateful to my fellow Californian’s for passing this important measure.  And I am very appreciative of this Governor’s leadership to transform our behavioral health care system!”
    • Assemblymember Jacqui Irwin (D-Thousand Oaks), author of Assembly Bill 531: “This started as an audacious proposal to address the root cause of homelessness and today, Californians can be proud to know that they did the right thing by passing Proposition 1. Now, it’s time for all of us to get to work, and make sure these reforms are implemented and that we see results.”

    Bigger picture: Transforming the Mental Health Services Act into the Behavioral Health Services Act and building more community mental health treatment sites and supportive housing is the last main pillar of Governor Newsom’s Mental Health Movement – pulling together significant recent reforms like 988 crisis line, CalHOPE, CARE Court, conservatorship reform, CalAIM behavioral health expansion (including mobile crisis care and telehealth), Medi-Cal expansion to all low-income Californians, Children and Youth Behavioral Health Initiative (including expanding services in schools and on-line), Older Adult Behavioral Health Initiative, Veterans Mental Health Initiative, Behavioral Health Community Infrastructure Program, Behavioral Health Bridge Housing, Health Care Workforce for All and more.

    More details on next step here

    Press releases, Recent news

    Recent news

    News What you need to know: The $101 million being made available today will support the development of affordable multifamily rental housing in Los Angeles, prioritizing the needs of displaced residents in the fire-devastated regions. Los Angeles, California – Six…

    News SACRAMENTO – Governor Gavin Newsom today announced the deployment of an additional 18 highly skilled Urban Search and Rescue Team members to Texas to assist with ongoing response efforts related to severe flooding impacts.The deployment includes a total of four…

    News Perris, California — On June 18, 2025, the First Partner visited the Inland Empire to meet with California communities impacted by the Trump Administration’s federal immigration raids. The First Partner visited TODEC, a local nonprofit organization that’s become…

    MIL OSI USA News

  • MIL-OSI New Zealand: Healthcare – Government must save Tōtara Hospice: NZNO

    Source: New Zealand Nurses Organisation

    The Coalition Government must provide urgent funding to Totara Hospice to stop it having to cut its services by a quarter from next week, NZNO says.
    Totara Hospice provides end-of-life care at no direct cost to patients from a diverse and growing community of around 520,000 South Aucklanders and is the subject of a new documentary series called Hospice Heroes.
    New Zealand Nurses Organisation Tōpūtanga Tapuhi Kaitiaki o Aotearoa (NZNO) delegate and hospice nurse Ed Boswell-Correa said staff were yesterday told the hospice had to reduce the number of people they actively care for in a month from 420 to 320 because of a lack of Government funding.
    “This decision is devastating for the local community. It will mean only the sickest people will be able to access our services.
    “It will force elderly people to remain in aged care facilities when they need specialist palliative care. Other people will be forced to go to Middlemore Hospital for care or worse still, not receive the care they need at all.
    “These people deserve the dignity they are provided by hospice when they are dying.”
    Ed Boswell-Correa says yesterday’s “bombshell announcement” follows a hiring freeze Totara was forced to put in place last month.
    “Fewer nurses and health care assistants mean less care for our patients. We want to be able to provide our patients and their whānau with the health care they need at this traumatic time in their lives,” he says.
    Sadly, Totara Hospice isn’t alone. NZNO is aware of at least four other hospices having to reduce their services. The Coalition Government must provide Te Whatu Ora with the funding it needs to save these services now.
    A report in March found hospices provide taxpayers with at least $1.59 in health benefits for every dollar of government funding. 

    MIL OSI New Zealand News

  • MIL-OSI Asia-Pac: LCQ18: Hong Kong elderly people spending retirement years in the Mainland

    Source: Hong Kong Government special administrative region – 4

         Following is a question by the Hon Erik Yim and a written reply by the Secretary for Health, Professor Lo Chung-mau, in the Legislative Council today (July 9):

    Question:

         The 2024 Policy Address proposes to strengthen elderly services and foster an elderly-friendly building environment. There are views pointing out that the choice of Hong Kong elderly persons to spend their retirement years in the Mainland, particularly other Mainland cities of the Guangdong-Hong Kong-Macao Greater Bay Area (GBA), can not only improve elderly persons’ quality of life, but also free up valuable living space in Hong Kong and ease the burden of public welfare on the Government. Moreover, amid the recent significant adjustments in property prices in the Mainland, such as areas like Huidong County in Huizhou and Shaxi Town in Zhongshan, some members of the public have proposed that the SAR Government may study the construction or purchase of buildings in the Mainland with better views, affordable rents, and more spacious and brighter interiors at lower costs for use as public rental housing (PRH), so as to provide Hong Kong elderly people with new opportunities to spend their retirement years in the Mainland. In this connection, will the Government inform this Council:

    (1) whether it will consider acquiring vacant properties pending sale in the Mainland cities of GBA for use as PRH flats with which the elderly people can replace their existing PRH flats in Hong Kong, thereby encouraging them to spend their retirement years in the Mainland cities of GBA; if so, of the details;

    (2) given that at present, under the Pilot Scheme for Direct Cross-boundary Ambulance Transfer in the Greater Bay Area, arrangements can be made for patients to be transferred directly from designated sending hospitals in Shenzhen to designated public hospitals in Hong Kong in a point-to-point mode, whether the Government will further deepen the collaboration mechanism concerned by expanding the scope of the pilot scheme this year to cover other major cities in GBA and include emergency cases, so that emergency transport to Hong Kong can be arranged when necessary for elderly patients retiring in such cities, with a view to increasing the incentive for them to go north for retirement; and

    (3) whether it will strengthen collaboration with the Mainland cities of GBA, such as jointly promoting remote diagnosis and AI medical consultation, to enhance healthcare service efficiency, as well as driving the development of gerontechnology and relevant industries, thereby better supporting Hong Kong people in spending their retirement years in such Mainland cities?

    Reply:

    President,

         The Hong Kong Special Administrative Region (HKSAR) Government has been following the principle of complementarity and mutual benefits to enhance co-operation with Mainland cities of the Guangdong-Hong Kong-Macao Greater Bay Area (GBA), on the premise of benefitting the development of Hong Kong and the Mainland, so as to provide more options and convenience for Hong Kong residents who choose to work, reside or retire on the Mainland.

         Having consulted the Housing Bureau, the Labour and Welfare Bureau, the Department of Health and the Hospital Authority (HA), the reply to the question raised by the Hon Erik Yim is as follows:

    (1) The Housing Bureau has all along been supporting the implementation of various strategies and policies to cope with an ageing population. In order to strengthen the support to those who choose to retire on the Mainland, the Housing Bureau makes flexible arrangement for elderly public rental housing (PRH) residents who are required to surrender their PRH flats or delete their names from the tenancies upon receiving portable cash assistance. Considering Hong Kong elderly persons may encounter adaptation issues after moving to the Mainland, the Hong Kong Housing Authority and the Hong Kong Housing Society allow elderly persons to retain their PRH flats or their names in the tenancies for no more than six months, with the grace period starting from the date of the elderly persons’ departure from Hong Kong. The above measure could address elderly persons’ concern about moving to the Mainland and help release PRH flats for turnover.

    (2) The study on the provision of land-based cross-boundary transfer for non-emergency and non-critically ill patients and the exploration of rolling out a pilot co-operation scheme for cross-boundary referral of patients between designated hospitals were put forward in the Outline Development Plan for the GBA. The Chief Executive of the HKSAR also put forward in his 2023 Policy Address the initiative to explore cross-boundary ambulance transfer arrangements between hospitals in the GBA. With the support of various national ministries, the HKSAR Government, in collaboration with the Guangdong Provincial Government, the Shenzhen Municipal Government and the Macao SAR Government, officially launched the one-year Pilot Scheme for Direct Cross-boundary Ambulance Transfer in the Greater Bay Area (Pilot Scheme) on November 30, 2024.

         The Pilot Scheme starts by arranging direct cross-boundary ambulance transfer of patients from designated sending hospitals in Shenzhen and Macao (i.e. the University of Hong Kong – Shenzhen Hospital (HKU-SZH) and the Conde S. Januario Hospital of Macao) to designated public hospitals in Hong Kong. Upon assessment and agreement by the teams of designated cross-boundary collaborating hospitals, arrangements can be made for patients with specific clinical needs and suitable clinical conditions (including that the conditions are relatively stable) to be transferred directly to Hong Kong between designated hospitals in a point-to-point mode without the handover of patients between ambulances at boundary control points, thus minimising risks posed to patients during transfer. Indeed, persons with urgent medical needs should receive treatment at the nearest medical facility. Therefore, the Pilot Scheme does not cover emergency cases.

         Subject to the effectiveness and operational experience of the Pilot Scheme, the governments of Guangdong, Hong Kong and Macao will consider how to extend the Pilot Scheme, such as including more designated hospitals (including those in GBA Mainland cities other than Shenzhen) and/or extending the Pilot Scheme to a two-way arrangement.

    (3) As mentioned above, the HKSAR Government will follow the principle of complementarity and mutual benefits to strengthen the collaboration with Mainland cities of the GBA. Indeed, the resources, needs, relevant laws and regulations, and regulatory regimes differ between Hong Kong and the Mainland. The HKSAR Government will explore cross-boundary facilitation measures on the premise that these cross-boundary measures are feasible and mutually beneficial.

         Specifically, the Government has been implementing various measures to facilitate the retirement of Hong Kong elderly persons in Mainland cities of the GBA, including providing subsidised residential care services and portable cash assistance. Among them, the Residential Care Services Scheme in Guangdong provides an additional choice for eligible Hong Kong elderly persons to receive subsidised residential care services. The Labour and Welfare Bureau signed a “Letter of Intent on Collaboration to Expand the Residential Care Services Scheme in Guangdong” with the Department of Civil Affairs of Guangdong Province in November 2023 to co-operate in selecting suitable residential care homes for the elderly operated by Mainland organisations in Mainland cities of the GBA for joining the Scheme. With the assistance of the relevant authorities, the number of residential care homes for the elderly in Guangdong joining the Scheme has increased to 15, scattering in six Mainland cities within the GBA. The Government has, starting from this May, commissioned a non-governmental organisation to provide Social and Care Support Service for the elderly participants of the Scheme and their families, and will launch a two-year pilot arrangement by the end of this year to share part of the medical expenses that the elderly participants of the Scheme need to bear on their own under the National Basic Medical Insurance Policy.

         In terms of healthcare services, the public or subsidised healthcare services provided by the HKSAR Government are based on catering for the needs of local Hong Kong residents, rather than the healthcare needs of Hong Kong residents on the Mainland or overseas. Nevertheless, the Government has been actively promoting GBA healthcare collaboration in recent years to provide Hong Kong residents, who regularly travel to and from Mainland cities in the GBA for work or living, with additional choices of subsidised healthcare services comparable to those in Hong Kong at designated service points on the Mainland. Such measures, however, are not intended to fully cater for the healthcare services required by Hong Kong residents who choose to settle on the Mainland. Examples include:

    (i) The Government launched the Elderly Health Care Voucher Greater Bay Area Pilot Scheme in 2024 to extend the coverage of the Elderly Health Care Vouchers (EHCVs) to seven integrated medical/dental institutions in Mainland cities of the GBA, offering more convenience and flexibility for eligible Hong Kong elderly persons by providing more service points in the GBA for them to better use their EHCVs on primary healthcare services to improve health conditions. The Government announced this May to extend the said Pilot Scheme and to increase 12 additional pilot medical institutions to cover all nine Mainland cities in the GBA. Among the 12 additional pilot medical institutions, four (viz. two located in Zhuhai and one each in Zhongshan and Guangzhou) launched the service on June 26 and July 9 respectively, while another two new service points in Foshan will launch the service on July 17. It is expected that the remaining six pilot medical institutions will launch the service gradually in the second half of this year. By then, together with the two existing service points operated by the HKU-SZH, eligible Hong Kong elderly persons can use the EHCVs at a total of 21 service points in Mainland cities of the GBA.

    (ii) The Government announced this March the extension of the Pilot Scheme for Supporting Patients of the HA in the GBA till March 31, 2026, with a view to enabling eligible patients of the HA to choose to receive subsidised consultation services at the designated collaborating healthcare institution in the GBA. The Scheme aims to provide Hong Kong people with more choices when receiving HA’s services, and is currently applicable to the HKU-SZH. The Government and the HA will evaluate the effectiveness and the scope of services of this Pilot Scheme each year and make necessary adjustments in a timely manner.

    (iii) In order to enhance the continuity of medical care for elderly persons through facilitating their secure use of electronic health records across the boundary, the Government has progressively launched the new functions of “Cross-boundary Health Record” and “Personal Folder” of the eHealth mobile application (eHealth App) at the HKU-SZH and the seven medical institutions under the Elderly Health Care Voucher Greater Bay Area Pilot Scheme since July 2024. The two functions have will be progressively extended to the new medical institutions under the said Pilot Scheme this year. In addition, elderly persons and their carers can also use the eHealth App to check their EHCV balance and usage record, as well as access at any time important information stored in the eHealth App, such as their medications, allergies and adverse drug reactions.

         Separately, the Ministry of Human Resources and Social Security and the National Healthcare Security Administration promulgated the Interim Measures for Participation in Social Insurance by Hong Kong, Macao and Taiwan Residents on the Mainland in 2019, allowing eligible Hong Kong residents to participate in the national health insurance schemes on the Mainland.

    MIL OSI Asia Pacific News

  • MIL-OSI United Kingdom: Russia’s illegal war in Ukraine continues to have a devastating impact on children: UK statement to the OSCE

    Source: United Kingdom – Executive Government & Departments

    Speech

    Russia’s illegal war in Ukraine continues to have a devastating impact on children: UK statement to the OSCE

    Deputy Ambassador James Ford condemns the grave violations Russian armed forces and authorities have committed against children in Ukraine, including through attacks on schools and hospitals.

    Thank you, Madam Chair. Thank you, Mr Chair.  I would also like to thank the speakers for their insights on the important and emotive topic we are dealing with today. 

    The United Kingdom is deeply concerned about the worsening situation for children in conflicts around the world.  More grave violations against children were verified by the UN than ever before in 2024, and instances of rape and other forms of sexual violence against children increased by 35% compared to 2023. 

    Regrettably, Madam Chair, our own region has not been immune from this trend.  Russia’s illegal invasion of Ukraine continues to have a harrowing effect on Ukraine’s 7.5 million children – on their health, education, family life and prospects for their futures. 

    In 1999, UN Security Council Resolution 1261 defined ‘Six Grave Violations’ most frequently affecting children in times of war. According to the latest UN report on children and armed conflict, there is mounting evidence that Russian authorities and Russian armed forces have committed at least five of these Six Grave Violations in Ukraine.  For consecutive years, the UN Secretary General has reported that under two categories – the killing and maiming of children, and attacks on schools and hospitals – the violations committed by Russian armed forces are prolific enough to warrant formal listing in his annual report.

    A case in point is the attack on the Okhmatdyt Children’s Hospital in Kyiv.  Yesterday marked one year since a Russian KH-101 cruise missile struck the hospital. It was the biggest children’s medical facility in Ukraine and the country’s primary provider of specialist paediatric care.

    According to UNICEF’s report from November 2024, the war has killed or injured over 2,406 children – an average of sixteen children every week.  The UN verified 222 cases of children being killed or injured in Ukraine between 1 March and 31 May 2025 – three times more children killed than during the previous quarter. In April this year alone, 97 children were killed or maimed. According to UN statistics, that is the highest monthly number of child casualties since June 2022.

    It is not just death or injury that Ukrainian children face on a daily basis.  According to the Government of Ukraine, the Russian authorities and armed forces have deported nearly 20,000 Ukrainian children to Russia and the temporarily occupied territories.  UN reports detail the treatment of Ukrainian children in these territories. Russian authorities have systematically forced the introduction of Russian language curriculum in schools, as well as ‘military-patriotic’ training. They have also forced Ukrainian children to adopt Russian citizenship.  Save the Children estimates that Russian attacks destroyed or damaged 576 education facilities in 2024 – more than double the 256 of the year before.

    UN and Save the Children reports also underline that children fleeing the fighting in Ukraine are at significant risk of family separation, abuse, violence, sexual exploitation, and trafficking.  Countless people will bear the social and psychological trauma for years to come.  

    Moscow continues to try to disguise these crimes through a campaign of denial and disinformation.  But these abuses have all been verified by independent sources, including the UN, ODIHR and reports commissioned under the OSCE’s Moscow Mechanism.

    As we all know, and as the speakers have detailed today, children are uniquely vulnerable and disproportionately affected by conflict.  We welcome the OSCE’s work to hold Russia accountable for its actions and to support Ukraine, including through the SPU, the Support Programme for Ukraine.  And we call on Russia to cease this unprovoked, illegal war and immediately and unconditionally return forcibly deported children to Ukraine. 

    Thank you.

    Updates to this page

    Published 9 July 2025

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: BMA resident doctor ballot outcome

    Source: United Kingdom – Executive Government & Departments 2

    Correspondence

    BMA resident doctor ballot outcome

    The Secretary of State for Health and Social Care writes to the co-chairs of the BMA Resident Doctor Committee.

    Documents

    Details

    The Rt Hon Wes Streeting MP writes to Dr Melissa Ryan and Dr Ross Nieuwoudt, co-chairs of the BMA Resident Doctor Committee, following the BMA resident doctor ballot outcome.

    Updates to this page

    Published 9 July 2025

    Sign up for emails or print this page

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Expanding care for patients at home

    Source: Scottish Government

    Improving the flow of patients through hospitals.

    A new £85 million investment will be targeted at front line NHS frailty services, helping to improve the flow of patients throughout hospitals and providing care for patients in the comfort of their own homes.

    The ‘Hospital at Home’ service is to be expanded to 2,000 beds by December 2026. It predominantly provides care for frail, older people in their own homes and who may be suffering with acute illnesses and health conditions, including respiratory and cardiac conditions, infections, or treatment after a fall.

    Keeping patients in their own homes ensures they can stay in familiar surroundings rather than be separated from family, friends and pets while also helping to reduce some of the risks associated with hospitalisations such as acquiring infections and lessening delayed discharge from hospital due to waits for appropriate care provision.

    The funding will also be used to support the introduction of frailty services in every A&E department by the end of summer 2025, aiming to cut the average length of stay for vulnerable patients.

    Speaking during a visit to Falkirk Community Hospital, where he met clinicians leading the Hospital at Home service across NHS Forth Valley, First Minister John Swinney said:

    “I am resolutely focused on taking the necessary action to reduce wait times and clear the blockages leading to delayed discharges across our NHS. This investment will ensure many patients can receive first class NHS care in the comfort of their own homes and not have to travel to a hospital where it isn’t required.

    “Expanding Hospital at Home to 2,000 beds by December 2026 will create the largest ‘hospital’ in the country, thereby improving the flow of patients throughout the NHS and generating greater capacity for staff. The staff delivering this service at Falkirk Community Hospital are testament to the success of Hospital at Home and it’s been eye opening to see the effort that goes into provide this first class care.

    “The NHS is Scotland’s greatest treasure but we know we must do better to ensure patients get the care they need, when and where they need it. The 2025-26 Budget provides record funding of £21 billion for Health and Social Care services – with NHS boards across Scotland receiving an additional £2 billion to deliver key front line services.”

    Dr Sarah Henderson, Consultant Geriatrician, NHS Forth Valley’s Hospital at Home Service, said:

    “Our local Hospital at Home team do an amazing job to help ensure that patients, who in the past would have to come into hospital, are able to remain in their own homes and access the specialist clinical care and support they require.

    “Over the last four years the service has helped thousands of local patients and the feedback we have received from them and their families has been overwhelmingly positive as they really appreciate everything the team does to help them stay out of hospital and in familiar surroundings at home, close to their family, friends and pets.

    “I am delighted that the additional funding announced today will help us expand the Hospital at Home service further as well as develop local heart failure, respiratory and Outpatient Parenteral Antimicrobial Therapy (OPAT) services to help more people remain at home and still access the specialist care they require.” 

    Marion Denholm’s husband Bill was recently supported by NHS Forth Valley’s Hospital at Home team after he developed a chest infection. Ms Denholm said:

    “There are no words to adequately describe the care and attention my husband received while under the care of Hospital at Home. We’ve had doctors, advanced nurse practitioners, physiotherapists, occupational therapists, a dietitian and a speech and language therapist all visit our home to provide the care and treatment he required so he didn’t have to go into hospital.

    “This meant he was able to stay in familiar surroundings with his family around him at all times and still receive the same type of care he would have received in hospital. I also felt very supported as I could contact the Team direct if I had any worries or concerns. I can’t praise the Hospital at Home service enough and I am sure many other local families feel the same. It also makes so much more sense to treat people in their own homes if you can rather than occupy a bed in a busy hospital – it’s definitely a win-win for everyone involved.”

    Background

    NHS Scotland Operational Improvement Plan

    MIL OSI United Kingdom

  • MIL-OSI Africa: Gauteng’s Rustervaal Clinic closes temporarily

    Source: Government of South Africa

    Gauteng’s Rustervaal Clinic closes temporarily

    The Gauteng Department of Health has announced the temporarily closure of the Rustervaal Clinic for safety reasons emanating from infrastructural challenges.

    “During the temporary closure, patients are advised to access health services from neighbouring public health facilities. Furthermore, there will be daily transportation via the Gauteng Scheduled Emergency Transport (G-SET) to and from Rustervaal Clinic to Market Avenue Clinic in Vereeniging between Monday to Friday at 8 am,” said the department.

    The clinic, which serves the community of Emfuleni, including Rochnee, Springcol and the Ramaphosa informal settlement closed on Monday.

    “The Department of Employment and Labour has issued a prohibition notice preventing the use of the Rustervaal Clinic until the identified infrastructural challenges (such as the dilapidated sections of building, collapsing ceiling in one of the rooms, poor electrical network in another section) are addressed. 

    “The Gauteng Department of Health affirms its commitment to addressing the infrastructural challenges at Rustervaal Clinic as part of the broader Infrastructure Revitalisation Plan that is underway across all five health districts in the province,” said the department in a statement on Tuesday.

    The plan includes not only rehabilitating existing infrastructure, but also constructing new facilities to meet the increasing demand. 

    “It is not yet clear how long the clinic will be closed. This will be subject to a full assessment of the facility and budget reallocation. However, as part of the commitment to expand access to healthcare services for the growing community of Emfuleni, work is already underway to convert Johan Heyns Community Health Centre (CHC) into a district hospital. 

    “This will improve access to quality health care by expanding primary health care and specialist services to both in-patients and outpatients, ultimately reducing the volume of referrals to Sebokeng Regional Hospital.”

    The provincial department assured the community of Emfuleni that the required infrastructural upgrades at the clinic is receiving urgent attention and appeals for cooperation as patients are diverted to nearby facilities. – SAnews.gov.za

    Neo

    MIL OSI Africa

  • MIL-OSI United Kingdom: Schools recognised for championing emotional wellbeing

    Source: City of Wolverhampton

    The event, held at Fordhouses Cricket Club, marked a significant milestone in Wolverhampton’s journey to embed emotional wellbeing and trauma-informed practice at the heart of education through the Wolverhampton ATTUNE Project — a two-year City of Wolverhampton Council-led programme that supports schools in embedding sustainable, trauma-informed practices.

    Schools progress through Bronze, Silver, and Gold levels, each recognising deeper integration of the ATTUNE principles – to be attachment-aware and trauma-informed, to build trust and understanding individual needs, to use nurturing and consistent approaches, and to ensure emotional wellbeing is a whole-school priority.

    The seven schools – Loxdale Primary, Broadmeadow Special School, Khalsa Academy, St Peter’s Collegiate Academy, St Michael’s C of E Primary, Christ Church Infant and Junior School, and Low Hill Nursery – were part of the original trauma-informed pilot and have now successfully achieved an ATTUNE award.

    Their efforts have led to meaningful changes in school culture, teaching practices, and student support systems, and each school was invited to receive their award and share stories of transformation, from improved student engagement to stronger staff-pupil relationships.

    Councillor Obaida Ahmed, Cabinet Member for Health, Wellbeing and Community, said: “We came together to recognise and celebrate the incredible efforts of several local schools in achieving the ATTUNE Charter. These schools have shown what it truly means to be attachment-aware, trauma-informed, and nurturing in their approach to education.”

    Councillor Jacqui Coogan, Cabinet Member for Children, Young People and Education, added: “This has been a wonderful opportunity to hear first-hand about the positive changes these schools have made. I would encourage schools who are not already part of ATTUNE but would like to be, to register their interest for the next programme beginning in spring 2026.”

    To register an interest, schools should please visit ATTUNE
     

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Supporting people on their recovery journey from addiction

    Source: City of York

    City of York Council is leading by example to support more people on their journey to recovery from addiction.

    The council is actively working with a number of recovery organisations in York to bring a city centre recovery hub to life, as well as making steps towards becoming a champion for York as an Inclusive Recovery City, tackling stigma and discrimination against people with addictions and celebrating their recovery by making it visible.

    Drugs and alcohol continue to present major issues for health and wellbeing in York. They lead to early illness and death, and in fact are the two leading causes of death in York for those between the ages of 15 and 49.

    They give rise to thousands of hospital admissions a year, worsen or lead to the onset of mental health conditions, and precipitate a large range of consequent physical health issues.

    They also present a city issue, and interact considerably with significant issues around housing, criminal justice, community cohesion, employment and safety, holding people back from living thriving and empowered lives.

    Nationally, the approach to supporting people with drug and alcohol issues has developed significantly over the last decades, from a sole emphasis on treatment and clinical services, such as substitution therapy, to a much greater focus on recovery.

    The council wants to strengthen York’s community recovery model, to further these aims and improve the lives of people affected by addictions in York.

    Whilst there has been and continues to be various activities taking place around recovery in the city, they have never had a home to develop and grow.

    The hub, based on Wellington Row, will make it easier for people with substance use disorders to seek help. This is set to be endorsed by the council’s Executive when they’re asked to support a new contract at a public meeting on 15 July, to award York in Recovery CIC to lease and manage the Community Recovery Hub.

    Cllr Lucy Steels- Walshaw, Executive Member for Health, Wellbeing and Adult Social Care at City of York Council, said:

    The recovery hub is providing a recovery-oriented facility to those residents who need this type of specialist support, in the heart of York. Endorsement of the Inclusive Recovery Cities initiative shows a strong council commitment to making recovery accessible and sustainable for more people, while sending a strong signal that those in recovery in our city have the right support behind them on their journey.”

    These community connections have been going for many years, with pop-up cafes, meetings, activities, support and social events happening most days of the week.

    Organisations including SMART UK, Alcoholic Anonymous, Narcotics Anonymous, Cocaine Anonymous, York in Recovery, Lived Insights, as well as charities such as Chocolate & Co and the treatment providers Change Grow Live and Emerging Futures, facilitate a vibrant recovery community in York involving many thousands of people.

    A pilot of how a Community Recovery Hub could work took place 18 months ago, and the opportunity has now come to The Hub, Wellington Row, which is owned by the council, as a more permanent base for this work

    Mark Green from York in Recovery said

    At York In Recovery, we know from lived experience that stigma is one of the greatest barriers preventing people from reaching out for the help they need when struggling with substance use.  Stigma isolates people, delays access to support and too often costs lives.

    “Recovery from addiction can be as lonely as when in addiction, we can all play our part in changing that narrative because recovery is real and when the right help support, and compassion are offered at the right time, people not only survive – they thrive.

    “The Recovery Hub will be a place for recovery curious individuals as much as for those who are already in the recovery community, it will be a beacon of hope to many and will support the work underway with the Inclusive Recovery Cities initiative.

    “York In Recovery are excited about the future and what will grow from the Recovery Hub.”

    Supporting the hub is one step towards supporting people’s journey in recover by the council wants to take this a step further.

    York wants to follow in the footsteps of other countries including America, Australia and New Zealand who have all championed the ‘inclusive recovery cities movement.’ Closer to home Middlesbrough – became the first official Inclusive Recovery City in 2024.

    Championed by Professor David Best, the movement makes recovery visible, giving hope to those currently experiencing substance use problems and providing ongoing support to those who are in recovery from substance use disorders.

    It challenges the stigma which can stop people coming forward for help, contributing to further harm, including as serious as death, for those with substance use disorders. It champions multiple pathways to recovery from substance use disorders and recognises that through doing this, the whole city will benefit.

    The Executive will be asked to express the council’s commitment to the Inclusive Recovery Cities approach and York’s Inclusive Recovery City Vision statement.

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Leeds City Council participates in international programme to tackle LGBT+ discrimination

    Source: City of Leeds

    Leeds City Council is to partner with Portuguese city Oeiras on a new project to tackle anti-LGBT+ discrimination by improving understanding between different communities.

    The five-month long Rainbow Connections project is funded through the Council of Europe’s Intercultural Cities (ICC) programme. It will see the two local authorities work with their LGBT+ staff and local non-governmental organisations in a series of awareness-raising sessions bringing together LGBT+ people and the wider community.

    The project will also examine how organisations interact with their own LGBT+ employees and communities and aims to help create good practice and ultimately to produce a training pack that can be shared and applied internationally.

    As part of the project, Leeds City Council will share its experiences and learning on the development of a successful LBGT+ staff network, as well as the development and implementation of the “what makes us different, makes us Leeds” anti-discrimination campaign, which included information and advice for communities to combat homophobia, biphobia, and transphobia,  offering Oeiras valuable insights as it develops its own initiatives in this important area.

    In both cities, the project’s objectives support longer-term plans for communities, where all voices feel included, and no group is left behind or ignored. It is hoped the project will also have a long-term legacy of acting as a catalyst for more regular, honest, and effective conversations between different communities in both local authorities and, indeed, internationally.

    Above: Oeiras Town Hall

    In Leeds, this project closely aligns with already well-established strategies for LGBT+ inclusion and will automatically be built into Leeds’s city-wide strategy.

    Deputy Leader and executive member for economy, transport and sustainable development, Councillor Jonathan Pryor, said: “Leeds is committed to being a city where everyone, whatever their identity or background, feels safe, welcomed and included, and that obviously includes our LGBT+ citizens.

    “Working with international partners provides a fresh perspective and an opportunity to exchange of ideas and working practices, so we are excited to work with like-minded cities such as Oeiras on tackling LGBT+ discrimination in all its forms”

    Councillor Fiona Venner, Executive Member for Equality, Health and Wellbeing, added

    “Many members of the LGBT+ community still face discrimination in some form, and that’s not the type of city Leeds wants to be. We have a responsibility to lead efforts to stop discrimination in all its forms, both in our city and elsewhere, and one of the best places to start is by encouraging better conversations and understanding.

    “We welcome funding from the Council of Europe’s Intercultural Cities programme to help us achieve this and further our aim to stop discrimination in all its forms, wherever it happens.”  

    MIL OSI United Kingdom

  • MIL-OSI Asia-Pac: LCQ9: Regulation of medical devices

    Source: Hong Kong Government special administrative region

    LCQ9: Regulation of medical devices 
    Question:
     
         At present, Hong Kong has only put in place a voluntary Medical Device Administrative Control System (the System), and there is no legislation to regulate such devices. On the other hand, it is learnt that some merchants are promoting and marketing parallel-imported contact lenses on the Internet, but these products do not have any medical device labelling on their packaging boxes, or the labelling shows signs of alteration (e.g. “the unique device identifier” has been cut off or covered), thus making it difficult to identify whether the products belong to problematic batches, and the quality of such products cannot be guaranteed. In this connection, will the Government inform this Council:
     
    (1) given that contact lenses is a class II medical device under the system, of the Government’s control over the importation and sale (including online sale) of contact lens products;
     
    (2) of the number of reports and requests for assistance received by the Government in the past three years in relation to parallel-imported contact lenses, as well as the categories of such cases (e.g. improper packaging labels, discomfort after use, etc.); whether it has taken law enforcement actions against merchants who have made unauthorised alterations to the packaging information of contact lenses (including parallel-imported contact lenses); if so, of the details; if not, the reasons for that; and
     
    (3) as the Government indicated in June last year that it was conducting a comprehensive review of the proposed legislative framework for medical device regulation, whether the Government will draw up a concrete timetable for introducing legislative amendments to regulate the manufacture, importation, quality assurance, sale and post-sale follow-up of medical devices; if so, of the details; if not, the reasons for that?
     
    Reply:
     
    President,
     
         In consultation with the Commerce and Economic Development Bureau, the Customs and Excise Department (C&ED) and the Department of Health (DH), the Health Bureau provides a consolidated reply to the question raised by Dr the Hon David Lam as follows:
     
         While there is not yet specific legislation to regulate medical devices in Hong Kong, some products are already regulated by existing pieces of legislation, such as the Pharmacy and Poisons Ordinance (Cap. 138), the Consumer Goods Safety Ordinance (CGSO) (Cap. 456) and the Trade Descriptions Ordinance (TDO) (Cap. 362) etc., depending on the characteristics and features of the products concerned.
     
         To safeguard public health, the DH has made reference to the recommendation of the Global Harmonization Task Force (now known as the International Medical Device Regulators Forum) and introduced the voluntary Medical Device Administrative Control System (MDACS) since 2004, under which a listing system for medical devices and traders as well as a post-market monitoring system for the products are put in place.  
     
         According to the prevailing MDACS, contact lenses are usually categorised as Class II (low-moderate risk) general medical devices. To apply for listing under the MDACS, a medical device must be proven to have met the requirements under the Essential Principles of Safety and Performance of Medical Devices that are adopted internationally. As for the listing system for traders (including local responsible person, local manufacturers, importers and distributors), traders must meet relevant requirements including holding a valid business registration certificate, maintaining a quality management system for supply of medical devices, and complying with post-market control for the products in order to hold them accountable for the safety of medical devices. Besides, a dedicated reporting system has been set up under the MDACS to handle the reporting of incidents pertaining to listed medical devices, with a view to enhancing protection for users via early detection of safety alerts.
     
         On the other hand, the C&ED is responsible for enforcing the CGSO and the TDO. The safety of consumer goods which are supplied for private use in Hong Kong, if not covered by other legislation, is subject to the regulation of the CGSO and its subsidiary legislation namely the Consumer Goods Safety Regulation (CGSR). This covers contact lenses as mentioned in the question.
     
         Pursuant to the CGSO, manufacturers, importers and suppliers should ensure that the consumer goods they supply are reasonably safe. The CGSR stipulates that any warning or caution marked on the package of consumer goods must be in both the English and the Chinese languages in a legible and conspicuous manner. Covering both goods and services, the TDO prohibits specified unfair trade practices deployed by traders against consumers, including false trade descriptions, misleading omissions, aggressive commercial practices, bait advertising, bait-and-switch and wrongly accepting payment, which are applicable to the commercial practices of both physical and online traders. 
     
         From 2022 to 2024, the C&ED did not receive any complaint on the product safety of contact lenses, but received six complaints of suspected contravention of the TDO. Upon investigation, five cases were closed due to insufficient evidence, with the remaining one under investigation. 
     
         Looking ahead, the DH has announced the establishment of the Hong Kong Centre for Medical Products Regulation (CMPR) by the end of 2026, with regulation of medical devices as part of its purview. The Government is taking forward preparatory work for the relevant legislation at full steam having regard to the latest international trends in regulation of medical devices in recent years, and will comprehensively review the proposed legislative framework. It is expected that the legislative proposal could be submitted to the Legislative Council within the next year so as to dovetail with the timetable for establishing the CMPR. Upon legislation, all medical devices supplied in Hong Kong, unless otherwise exempted, must be registered, thereby ensuring the compliance with relevant standards in safety, quality and performance. 
    Issued at HKT 15:30

    NNNN

    MIL OSI Asia Pacific News

  • MIL-OSI Asia-Pac: LCQ9: Regulation of medical devices

    Source: Hong Kong Government special administrative region

    LCQ9: Regulation of medical devices 
    Question:
     
         At present, Hong Kong has only put in place a voluntary Medical Device Administrative Control System (the System), and there is no legislation to regulate such devices. On the other hand, it is learnt that some merchants are promoting and marketing parallel-imported contact lenses on the Internet, but these products do not have any medical device labelling on their packaging boxes, or the labelling shows signs of alteration (e.g. “the unique device identifier” has been cut off or covered), thus making it difficult to identify whether the products belong to problematic batches, and the quality of such products cannot be guaranteed. In this connection, will the Government inform this Council:
     
    (1) given that contact lenses is a class II medical device under the system, of the Government’s control over the importation and sale (including online sale) of contact lens products;
     
    (2) of the number of reports and requests for assistance received by the Government in the past three years in relation to parallel-imported contact lenses, as well as the categories of such cases (e.g. improper packaging labels, discomfort after use, etc.); whether it has taken law enforcement actions against merchants who have made unauthorised alterations to the packaging information of contact lenses (including parallel-imported contact lenses); if so, of the details; if not, the reasons for that; and
     
    (3) as the Government indicated in June last year that it was conducting a comprehensive review of the proposed legislative framework for medical device regulation, whether the Government will draw up a concrete timetable for introducing legislative amendments to regulate the manufacture, importation, quality assurance, sale and post-sale follow-up of medical devices; if so, of the details; if not, the reasons for that?
     
    Reply:
     
    President,
     
         In consultation with the Commerce and Economic Development Bureau, the Customs and Excise Department (C&ED) and the Department of Health (DH), the Health Bureau provides a consolidated reply to the question raised by Dr the Hon David Lam as follows:
     
         While there is not yet specific legislation to regulate medical devices in Hong Kong, some products are already regulated by existing pieces of legislation, such as the Pharmacy and Poisons Ordinance (Cap. 138), the Consumer Goods Safety Ordinance (CGSO) (Cap. 456) and the Trade Descriptions Ordinance (TDO) (Cap. 362) etc., depending on the characteristics and features of the products concerned.
     
         To safeguard public health, the DH has made reference to the recommendation of the Global Harmonization Task Force (now known as the International Medical Device Regulators Forum) and introduced the voluntary Medical Device Administrative Control System (MDACS) since 2004, under which a listing system for medical devices and traders as well as a post-market monitoring system for the products are put in place.  
     
         According to the prevailing MDACS, contact lenses are usually categorised as Class II (low-moderate risk) general medical devices. To apply for listing under the MDACS, a medical device must be proven to have met the requirements under the Essential Principles of Safety and Performance of Medical Devices that are adopted internationally. As for the listing system for traders (including local responsible person, local manufacturers, importers and distributors), traders must meet relevant requirements including holding a valid business registration certificate, maintaining a quality management system for supply of medical devices, and complying with post-market control for the products in order to hold them accountable for the safety of medical devices. Besides, a dedicated reporting system has been set up under the MDACS to handle the reporting of incidents pertaining to listed medical devices, with a view to enhancing protection for users via early detection of safety alerts.
     
         On the other hand, the C&ED is responsible for enforcing the CGSO and the TDO. The safety of consumer goods which are supplied for private use in Hong Kong, if not covered by other legislation, is subject to the regulation of the CGSO and its subsidiary legislation namely the Consumer Goods Safety Regulation (CGSR). This covers contact lenses as mentioned in the question.
     
         Pursuant to the CGSO, manufacturers, importers and suppliers should ensure that the consumer goods they supply are reasonably safe. The CGSR stipulates that any warning or caution marked on the package of consumer goods must be in both the English and the Chinese languages in a legible and conspicuous manner. Covering both goods and services, the TDO prohibits specified unfair trade practices deployed by traders against consumers, including false trade descriptions, misleading omissions, aggressive commercial practices, bait advertising, bait-and-switch and wrongly accepting payment, which are applicable to the commercial practices of both physical and online traders. 
     
         From 2022 to 2024, the C&ED did not receive any complaint on the product safety of contact lenses, but received six complaints of suspected contravention of the TDO. Upon investigation, five cases were closed due to insufficient evidence, with the remaining one under investigation. 
     
         Looking ahead, the DH has announced the establishment of the Hong Kong Centre for Medical Products Regulation (CMPR) by the end of 2026, with regulation of medical devices as part of its purview. The Government is taking forward preparatory work for the relevant legislation at full steam having regard to the latest international trends in regulation of medical devices in recent years, and will comprehensively review the proposed legislative framework. It is expected that the legislative proposal could be submitted to the Legislative Council within the next year so as to dovetail with the timetable for establishing the CMPR. Upon legislation, all medical devices supplied in Hong Kong, unless otherwise exempted, must be registered, thereby ensuring the compliance with relevant standards in safety, quality and performance. 
    Issued at HKT 15:30

    NNNN

    MIL OSI Asia Pacific News

  • MIL-OSI Asia-Pac: LCQ9: Regulation of medical devices

    Source: Hong Kong Government special administrative region

    LCQ9: Regulation of medical devices 
    Question:
     
         At present, Hong Kong has only put in place a voluntary Medical Device Administrative Control System (the System), and there is no legislation to regulate such devices. On the other hand, it is learnt that some merchants are promoting and marketing parallel-imported contact lenses on the Internet, but these products do not have any medical device labelling on their packaging boxes, or the labelling shows signs of alteration (e.g. “the unique device identifier” has been cut off or covered), thus making it difficult to identify whether the products belong to problematic batches, and the quality of such products cannot be guaranteed. In this connection, will the Government inform this Council:
     
    (1) given that contact lenses is a class II medical device under the system, of the Government’s control over the importation and sale (including online sale) of contact lens products;
     
    (2) of the number of reports and requests for assistance received by the Government in the past three years in relation to parallel-imported contact lenses, as well as the categories of such cases (e.g. improper packaging labels, discomfort after use, etc.); whether it has taken law enforcement actions against merchants who have made unauthorised alterations to the packaging information of contact lenses (including parallel-imported contact lenses); if so, of the details; if not, the reasons for that; and
     
    (3) as the Government indicated in June last year that it was conducting a comprehensive review of the proposed legislative framework for medical device regulation, whether the Government will draw up a concrete timetable for introducing legislative amendments to regulate the manufacture, importation, quality assurance, sale and post-sale follow-up of medical devices; if so, of the details; if not, the reasons for that?
     
    Reply:
     
    President,
     
         In consultation with the Commerce and Economic Development Bureau, the Customs and Excise Department (C&ED) and the Department of Health (DH), the Health Bureau provides a consolidated reply to the question raised by Dr the Hon David Lam as follows:
     
         While there is not yet specific legislation to regulate medical devices in Hong Kong, some products are already regulated by existing pieces of legislation, such as the Pharmacy and Poisons Ordinance (Cap. 138), the Consumer Goods Safety Ordinance (CGSO) (Cap. 456) and the Trade Descriptions Ordinance (TDO) (Cap. 362) etc., depending on the characteristics and features of the products concerned.
     
         To safeguard public health, the DH has made reference to the recommendation of the Global Harmonization Task Force (now known as the International Medical Device Regulators Forum) and introduced the voluntary Medical Device Administrative Control System (MDACS) since 2004, under which a listing system for medical devices and traders as well as a post-market monitoring system for the products are put in place.  
     
         According to the prevailing MDACS, contact lenses are usually categorised as Class II (low-moderate risk) general medical devices. To apply for listing under the MDACS, a medical device must be proven to have met the requirements under the Essential Principles of Safety and Performance of Medical Devices that are adopted internationally. As for the listing system for traders (including local responsible person, local manufacturers, importers and distributors), traders must meet relevant requirements including holding a valid business registration certificate, maintaining a quality management system for supply of medical devices, and complying with post-market control for the products in order to hold them accountable for the safety of medical devices. Besides, a dedicated reporting system has been set up under the MDACS to handle the reporting of incidents pertaining to listed medical devices, with a view to enhancing protection for users via early detection of safety alerts.
     
         On the other hand, the C&ED is responsible for enforcing the CGSO and the TDO. The safety of consumer goods which are supplied for private use in Hong Kong, if not covered by other legislation, is subject to the regulation of the CGSO and its subsidiary legislation namely the Consumer Goods Safety Regulation (CGSR). This covers contact lenses as mentioned in the question.
     
         Pursuant to the CGSO, manufacturers, importers and suppliers should ensure that the consumer goods they supply are reasonably safe. The CGSR stipulates that any warning or caution marked on the package of consumer goods must be in both the English and the Chinese languages in a legible and conspicuous manner. Covering both goods and services, the TDO prohibits specified unfair trade practices deployed by traders against consumers, including false trade descriptions, misleading omissions, aggressive commercial practices, bait advertising, bait-and-switch and wrongly accepting payment, which are applicable to the commercial practices of both physical and online traders. 
     
         From 2022 to 2024, the C&ED did not receive any complaint on the product safety of contact lenses, but received six complaints of suspected contravention of the TDO. Upon investigation, five cases were closed due to insufficient evidence, with the remaining one under investigation. 
     
         Looking ahead, the DH has announced the establishment of the Hong Kong Centre for Medical Products Regulation (CMPR) by the end of 2026, with regulation of medical devices as part of its purview. The Government is taking forward preparatory work for the relevant legislation at full steam having regard to the latest international trends in regulation of medical devices in recent years, and will comprehensively review the proposed legislative framework. It is expected that the legislative proposal could be submitted to the Legislative Council within the next year so as to dovetail with the timetable for establishing the CMPR. Upon legislation, all medical devices supplied in Hong Kong, unless otherwise exempted, must be registered, thereby ensuring the compliance with relevant standards in safety, quality and performance. 
    Issued at HKT 15:30

    NNNN

    MIL OSI Asia Pacific News

  • European heatwave caused 2,300 deaths, scientists estimate

    Source: Government of India

    Source: Government of India (4)

    Around 2,300 people died of heat-related causes across 12 European cities during the severe heatwave that ended last week, according to a rapid scientific analysis published on Wednesday.

    The study targeted the 10 days, ending July 2, during which large parts of Western Europe were hit by extreme heat, with temperatures breaching 40 degrees Celsius (104°F) in Spain and wildfires breaking out in France.

    Of the 2,300 people estimated to have died during this period, 1,500 deaths were linked to climate change, which made the heatwave more severe, according to the study conducted by scientists at Imperial College London and the London School of Hygiene and Tropical Medicine.

    “Climate change has made it significantly hotter than it would have been, which in turn makes it a lot more dangerous,” said Dr Ben Clarke, a researcher at Imperial College London.

    The study covered 12 cities including Barcelona, Madrid, London and Milan, where the researchers said climate change had increased heatwave temperatures by up to 4 degrees Celsius.

    The researchers used established epidemiological models and historical mortality data to estimate the death toll, which reflects deaths where heat was the underlying reason for mortality, including if exposure exacerbated pre-existing health conditions.

    The scientists said they used peer-reviewed methods to quickly produce the estimated death toll, because most heat-related deaths are not officially reported and some governments do not release this data.

    Last month was the planet’s third-hottest June on record, behind the same month in 2024 and 2023, the EU’s Copernicus Climate Change Service said in a monthly bulletin on Wednesday.

    Western Europe experienced its warmest June on record, with much of the region experiencing “very strong heat stress” – defined by conditions that feel like a temperature of 38 degrees Celsius or more, Copernicus said.

    “In a warming world, heatwaves are likely to become more frequent, more intense and impact more people across Europe,” said Samantha Burgess, Copernicus’ strategic lead for climate.

    Researchers from European health institutes reported in 2023 that as many as 61,000 people may have died in Europe’s sweltering heatwaves in 2022, according to new research, suggesting countries’ heat preparedness efforts are falling fatally short.

    The build-up of greenhouse gas emissions in the atmosphere – which mostly come from the burning of fossil fuels – means the planet’s average temperature has increased over time. This increase in baseline temperatures means that when a heatwave comes, temperatures can surge to higher peaks.

    (Reuters)

  • MIL-OSI United Nations: 9 July 2025 Departmental update WHO, UNICEF update country tracker on water, sanitation and hygiene in health-care facilities, showing progress across 107 countries

    Source: World Health Organisation

    The World Health Organization (WHO) and UNICEF have released an updated country progress tracker that shows how countries are advancing efforts to improve water, sanitation, hygiene (WASH) and waste services in health-care facilities. The tracker, now covering 107 countries – up from 75 two years ago – underpins global monitoring against the 2023 United Nations General Assembly Resolution on WASH, waste and electricity in health-care facilities.

    The tracker provides the most comprehensive picture yet of how countries are taking forward the eight practical steps to improve WASH services in health facilities, from establishing national standards to developing costed roadmaps, strengthening health information systems and building workforce capacity.

    “This data shows that nearly every country is taking action,” said Maggie Montgomery, Technical Officer at WHO. “We see strong momentum on developing national standards and conducting baseline assessments, but critical gaps remain. Only 17% of countries have secured sufficient financing to improve and sustain these essential services. That means patients, staff and communities continue to face unnecessary risks.”

    Half of healthcare facilities worldwide lack basic hygiene services with water and soap or alcohol-based hand rub where patients receive care and at toilets in these facilities, according to the latest Joint Monitoring Programme (JMP) report by WHO and UNICEF. Around 3.85 billion people use these facilities, putting them at greater risk of infection, including 688 million people who receive care at facilities with no hygiene services at all.

    The updated analysis also highlights encouraging trends. Over 90% of countries have undertaken baseline assessments or developed standards. Nearly half of countries updating WASH and waste guidelines are integrating climate resilience and sustainability considerations, such as installing safe water storage, using greener plumbing materials and expanding non-burn waste treatment.

    “We’ve seen that progress is possible even in the most challenging contexts,” said Lindsay Denny Naughton, WASH Specialist at UNICEF. “Where countries work on multiple areas at once – from standards to infrastructure to integrating WASH into national health monitoring – these efforts reinforce each other and drive system-wide improvements. It’s clear that equity, including addressing the needs of women, girls and people with disabilities, has to be central to these efforts.”

    The updated tracker comes ahead of a global webinar on 29 July, hosted by WHO and UNICEF, which will share country experiences and highlight what more is needed to meet the targets set in the 2023 UN Resolution. The forthcoming WHO/UNICEF Global Progress Report on WASH and waste in health-care facilities, to be launched in October 2025, will provide further insights based on these country updates.

    Last week, WHO Europe convened countries and partners in Budapest under the Protocol on Water and Health to explore how global commitments can be translated into action at the national level, including through better financing models and integrating WASH into broader health, climate and antimicrobial resistance strategies.

    Montgomery emphasized: “We know what actions need to be taken, we have the tools and evidence and investing makes sense. Every dollar spent on hand hygiene in health-care facilities yields a return of 25 dollars. Now is the time to translate this momentum into concrete, sustainable improvements.”

    MIL OSI United Nations News

  • MIL-OSI: 4BIO Capital co-leads Actithera’s oversubscribed $75.5 million Series A financing

    Source: GlobeNewswire (MIL-OSI)

    4BIO investing in unique radiopharmaceutical platform company, developing radioligands with prolonged tumour retention

    Series A was co-led by 4BIO Capital, founding investor M Ventures, Hadean Ventures, and Sofinnova Partners, with syndicate including Bioqube Ventures, Surveyor Capital (a Citadel company) and others

    Proceeds will support clinical development of Actithera’s fibroblast activation protein (FAP)-targeting candidate and pipeline expansion

    London, United Kingdom, 9 July 2025 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm unlocking the treatments of the future by investing in advanced therapies and other emerging technologies, today announces that it has co-led a $75.5 million Series A Financing round of Actithera (the “Company”).

    Radiopharmaceutical therapy (or radioligand therapy, RLT) is a targeted form of radiotherapy that can treat cancers resistant to other therapies and represents a $7.5 billion market projected to grow to $14.4 billion by 20341. RLTs with the appropriate pharmacokinetic profile can achieve efficacy with minimal toxicity; however, attaining the ideal pharmacokinetic characteristics is not trivial. 4BIO’s investment in Actithera highlights the clear need for a more systematic approach to optimizing RLT vectors and exemplifies the Group’s strategy of identifying critical technology gaps, backing innovative solutions, and supporting them in high-growth markets.

    4BIO co-led the oversubscribed round alongside founding investor M Ventures, Hadean Ventures, and Sofinnova Partners with additional participation from Bioqube Ventures, Innovestor’s Life Science Fund, Investinor, Surveyor Capital (a Citadel company), and the second founding investor, Arkin Bio Ventures II.

    Therese Liechtenstein, incoming Board Member and Investment Director at 4BIO Capital, said: “At 4BIO we invest in companies solving technical unmet needs to enable next-generation therapeutics. We are honoured to support Actithera, whose pipeline of molecules addresses key challenges in the nascent radioligand therapies space; a large therapeutic window through high tumour retention and low systemic exposure, applied to a lead programme that has significant pan-tumour therapeutic potential.”

    Dr Andreas Goutopoulous, Founder and CEO of Actithera, added: “We are grateful for 4BIO Capital’s support in this oversubscribed Series A, which is a strong validation of our approach. We set out to bring structure-based and kinetics-driven thinking from small molecule drug design into the world of radiopharmaceuticals. We engineer our radioconjugates for extended retention within tumours, making them ideally suited for longer-lived radionuclides and ultimately delivering more convenient dosing schedules and enhanced efficacy and safety for patients.”

    As part of the Series A financing, Therese Liechtenstein, Investment Director at 4BIO Capital will join the Actithera Board of Directors.

    The financing will support the advancement of Actithera’s lead FAP asset into clinical development in multiple indications, while also enabling the continued development of its proprietary RLT discovery platform and preclinical pipeline.

    The Company’s discovery platform combines rational drug design with radiochemistry to create novel small molecule radioligands that overcome current limitations in radiopharmaceutical development. Its three-pillar platform includes first-in-class covalent targeting strategies, designed to optimize tumour residence time, while ensuring rapid systemic clearance – improving precision, safety, and efficacy. Two additional proprietary approaches further support compound differentiation and improve tumour residence time and selectivity. This platform was validated through Actithera’s work on FAP, a high-value theranostic target known for being difficult to drug with molecules that maintain prolonged tumour residency. These efforts have resulted in a FAP-directed RLT development candidate with best-in-class potential due to its optimal pharmacokinetic profile and tumour specificity.

    Dr Andreas Goutopoulos, founder and CEO, brings over 25 years of pharmaceutical and biotech industry experience, including a track record of more than a dozen development candidates. His background includes over a decade of discovery leadership at EMD Serono, where he led medicinal chemistry. In his role as Entrepreneur-in-Residence (EIR) at M Ventures, he led the scientific efforts of and supported a number of oncology small molecule biotechs. At Actithera, he is pioneering a chemistry-driven, precision approach to RLTs by integrating novel covalent-targeting chemistries, rational drug design principles and an isotope-agnostic philosophy.

    – End –

    Contacts

    4BIO Capital +44 (0) 203 427 5500
    info@4biocapital.com
       
    ICR Healthcare
    Amber Fennell, Jonathan Edwards, Kris Lam
    +44 (0)20 3709 5700
    4biocapital@icrhealthcare.com

    About 4BIO Capital
    4BIO Capital (“4BIO”) is an international venture capital firm focused on investing in advanced therapies and emerging modalities, to unlock the treatments of the future. 4BIO’s mission is to invest in, support, and grow early-stage companies solving technical bottlenecks that enable next generation therapeutics in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially transformative therapies for all patients. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors with an unrivalled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space. For more information, connect with us on LinkedIn and Twitter @4biocapital and visit www.4biocapital.com.

    About Actithera
    Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs). Founded in 2021 by drug discovery innovator Dr. Andreas Goutopoulos, and seed investors M Ventures, and Arkin Bio-Holdings, Actithera applies various molecular design strategies, including covalent-targeting and an isotope-agnostic philosophy to invent RLTs with significant differentiation and larger therapeutic windows. Headquartered in Oslo, Norway, and Cambridge, Massachusetts, Actithera is committed to advancing a differentiated pipeline addressing critical unmet needs in oncology. Learn more at www.actithera.com and on LinkedIn.


    1 https://www.precedenceresearch.com/radiopharmaceuticals-market

    The MIL Network

  • MIL-OSI: 4BIO Capital co-leads Actithera’s oversubscribed $75.5 million Series A financing

    Source: GlobeNewswire (MIL-OSI)

    4BIO investing in unique radiopharmaceutical platform company, developing radioligands with prolonged tumour retention

    Series A was co-led by 4BIO Capital, founding investor M Ventures, Hadean Ventures, and Sofinnova Partners, with syndicate including Bioqube Ventures, Surveyor Capital (a Citadel company) and others

    Proceeds will support clinical development of Actithera’s fibroblast activation protein (FAP)-targeting candidate and pipeline expansion

    London, United Kingdom, 9 July 2025 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm unlocking the treatments of the future by investing in advanced therapies and other emerging technologies, today announces that it has co-led a $75.5 million Series A Financing round of Actithera (the “Company”).

    Radiopharmaceutical therapy (or radioligand therapy, RLT) is a targeted form of radiotherapy that can treat cancers resistant to other therapies and represents a $7.5 billion market projected to grow to $14.4 billion by 20341. RLTs with the appropriate pharmacokinetic profile can achieve efficacy with minimal toxicity; however, attaining the ideal pharmacokinetic characteristics is not trivial. 4BIO’s investment in Actithera highlights the clear need for a more systematic approach to optimizing RLT vectors and exemplifies the Group’s strategy of identifying critical technology gaps, backing innovative solutions, and supporting them in high-growth markets.

    4BIO co-led the oversubscribed round alongside founding investor M Ventures, Hadean Ventures, and Sofinnova Partners with additional participation from Bioqube Ventures, Innovestor’s Life Science Fund, Investinor, Surveyor Capital (a Citadel company), and the second founding investor, Arkin Bio Ventures II.

    Therese Liechtenstein, incoming Board Member and Investment Director at 4BIO Capital, said: “At 4BIO we invest in companies solving technical unmet needs to enable next-generation therapeutics. We are honoured to support Actithera, whose pipeline of molecules addresses key challenges in the nascent radioligand therapies space; a large therapeutic window through high tumour retention and low systemic exposure, applied to a lead programme that has significant pan-tumour therapeutic potential.”

    Dr Andreas Goutopoulous, Founder and CEO of Actithera, added: “We are grateful for 4BIO Capital’s support in this oversubscribed Series A, which is a strong validation of our approach. We set out to bring structure-based and kinetics-driven thinking from small molecule drug design into the world of radiopharmaceuticals. We engineer our radioconjugates for extended retention within tumours, making them ideally suited for longer-lived radionuclides and ultimately delivering more convenient dosing schedules and enhanced efficacy and safety for patients.”

    As part of the Series A financing, Therese Liechtenstein, Investment Director at 4BIO Capital will join the Actithera Board of Directors.

    The financing will support the advancement of Actithera’s lead FAP asset into clinical development in multiple indications, while also enabling the continued development of its proprietary RLT discovery platform and preclinical pipeline.

    The Company’s discovery platform combines rational drug design with radiochemistry to create novel small molecule radioligands that overcome current limitations in radiopharmaceutical development. Its three-pillar platform includes first-in-class covalent targeting strategies, designed to optimize tumour residence time, while ensuring rapid systemic clearance – improving precision, safety, and efficacy. Two additional proprietary approaches further support compound differentiation and improve tumour residence time and selectivity. This platform was validated through Actithera’s work on FAP, a high-value theranostic target known for being difficult to drug with molecules that maintain prolonged tumour residency. These efforts have resulted in a FAP-directed RLT development candidate with best-in-class potential due to its optimal pharmacokinetic profile and tumour specificity.

    Dr Andreas Goutopoulos, founder and CEO, brings over 25 years of pharmaceutical and biotech industry experience, including a track record of more than a dozen development candidates. His background includes over a decade of discovery leadership at EMD Serono, where he led medicinal chemistry. In his role as Entrepreneur-in-Residence (EIR) at M Ventures, he led the scientific efforts of and supported a number of oncology small molecule biotechs. At Actithera, he is pioneering a chemistry-driven, precision approach to RLTs by integrating novel covalent-targeting chemistries, rational drug design principles and an isotope-agnostic philosophy.

    – End –

    Contacts

    4BIO Capital +44 (0) 203 427 5500
    info@4biocapital.com
       
    ICR Healthcare
    Amber Fennell, Jonathan Edwards, Kris Lam
    +44 (0)20 3709 5700
    4biocapital@icrhealthcare.com

    About 4BIO Capital
    4BIO Capital (“4BIO”) is an international venture capital firm focused on investing in advanced therapies and emerging modalities, to unlock the treatments of the future. 4BIO’s mission is to invest in, support, and grow early-stage companies solving technical bottlenecks that enable next generation therapeutics in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially transformative therapies for all patients. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors with an unrivalled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space. For more information, connect with us on LinkedIn and Twitter @4biocapital and visit www.4biocapital.com.

    About Actithera
    Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs). Founded in 2021 by drug discovery innovator Dr. Andreas Goutopoulos, and seed investors M Ventures, and Arkin Bio-Holdings, Actithera applies various molecular design strategies, including covalent-targeting and an isotope-agnostic philosophy to invent RLTs with significant differentiation and larger therapeutic windows. Headquartered in Oslo, Norway, and Cambridge, Massachusetts, Actithera is committed to advancing a differentiated pipeline addressing critical unmet needs in oncology. Learn more at www.actithera.com and on LinkedIn.


    1 https://www.precedenceresearch.com/radiopharmaceuticals-market

    The MIL Network

  • MIL-Evening Report: Ice baths are booming in popularity – but they come with health risks

    Source: The Conversation (Au and NZ) – By Samuel Cornell, PhD Candidate in Public Health & Community Medicine, School of Population Health, UNSW Sydney

    Michele Ursi/Getty Images

    Walk through any trendy suburb and you might find a new “wellness” studio offering ice baths or “contrast therapy” (a sauna and ice bath combo).

    Scroll social media, and you’re likely to come across influencers preaching the cold plunge gospel with cult-like zeal.

    Ice baths have gone mainstream. Initially practised mainly among high-performance athletes, cold water immersion is now a booming business model: sold as recovery, discipline and therapy all in one.

    But the benefits are questionable and, importantly, ice baths can have health risks – particularly for people who have limited experience using them.

    From Roman times to today

    Cold water immersion isn’t a new concept.

    The “frigidarium” – a room with a cold plunge pool or bath – was a feature in most Roman bathhouses.

    For decades, athletes have used cold water immersion, such as swims in cold water, for recovery.

    But in recent years, with the proliferation of commercial cold plunge centres, there’s been an explosion in people using ice baths recreationally.

    Many people are even setting up their own ice baths at home. The global cold plunge tub market was valued at close to US$338 million in 2024 and is projected to reach nearly $483 million by 2033.

    Social media shows serene influencers meditating through the pain, claiming it boosts mental health, serotonin, testosterone, and their metabolism. But does the evidence stack up?

    Ice baths can reduce muscle soreness after intense training, however the effect is modest and short-lived.

    Some research shows cold water immersion can improve mood after a single exposure in young, healthy people, but other research doesn’t find these benefits.

    Most claims about mental health, testosterone and weight loss aren’t backed by strong evidence. Rather, they’re anecdotal and amplified by influencers.




    Read more:
    Cold water therapy: what are the benefits and dangers of ice baths, wild swimming and freezing showers?


    What does an ice bath involve?

    At commercial establishments, patrons can often use the ice baths as they please during a booked session. Ice bath temperatures often range anywhere from 3°C to 15°C. There normally isn’t actual ice in the bath, but some people add blocks of ice to their ice baths at home.

    Businesses offering ice baths don’t always actively supervise patrons or monitor a person’s time in the ice bath. They may leave their customers to self-regulate, assuming people will know to get out of the water before they pass their body’s limits.

    So what are the risks?

    Cold water immersion triggers a powerful physiological response. When you hit cold water below 15°C, your body launches into cold shock. Gasping occurs and breathing becomes rapid and uncontrollable. Heart rate spikes. Blood pressure rises.

    Staying in the water for too long can lead to hypothermia, a condition where a person’s core body temperature drops dangerously low.

    Shivering may begin within minutes in cold water. Confusion or fainting are more serious signs that hypothermia may be developing.

    Occasionally, this “cold shock” response can lead to a heart attack or stroke – especially if you have an undiagnosed condition affecting your heart, blood vessels or brain.

    As far back as 1969, researchers found even experienced swimmers could struggle after just a few minutes in cold water. Participants were immersed in water at 4.7°C while fully clothed and asked to swim as if trying to reach safety. Some developed serious respiratory distress and had to stop swimming within as little as 90 seconds, well before any measurable drop in core body temperature.

    Even after you get out, your core temperature can continue to fall – a phenomenon known as afterdrop. So you can encounter problems, such as collapse, even after leaving the water.

    And even young, healthy people can be caught off guard. The body isn’t designed to endure freezing water for extended periods.

    Recently one of us (Sam Cornell) had to provide first aid at an ice bath venue in Sydney. A young man collapsed after staying in an ice bath for ten minutes. He was shivering uncontrollably and clearly suffering from cold shock.

    Cold exposure can also cause long-term damage to nerves and blood vessels in the hands and feet, known as non-freezing cold injury. This is more likely if someone spends an extended period immersed in cold water. Symptoms such as numbness, pain and sensitivity to cold can persist for years.

    6 tips for safer recreational ice bath use

    The ice bath trend is part of a broader wellness movement, promoted to young men in particular, where discomfort is repackaged as discipline. Push through the pain. Master your body. If you feel terrible, you must be doing it right.

    But behind the hype lies a less appealing truth. Ice baths can be dangerous.

    We advise caution, but if you do choose to try an ice bath, treat it seriously and follow these tips to reduce the risk of harm.

    1. Talk to your doctor: get checked out first. If you or your family have any heart, stroke or respiratory risk, skip it

    2. Know your limits: being fit doesn’t protect you from cold shock

    3. Start gradually: begin with short warm to cold showers before full immersion

    4. Never go alone: always have someone with you, especially if you’re new to ice baths

    5. Keep it short and watch the temperature: limit sessions to 3–5 minutes and remember, problems can still occur after you get out

    6. Recognise the signs of danger: symptoms such as shivering, numbness and confusion can all seem like part of the experience to someone bent on pushing themselves. But these can be signs of hypothermia.

    Samuel Cornell receives funding from Meta Platforms, Inc. His research is supported by a University of New South Wales Sydney, University Postgraduate Award. His research is supported by Royal Life Saving Society – Australia to aid in the prevention of drowning. Research at Royal Life Saving Society – Australia is supported by the Australian government. He has been affiliated with Surf Life Saving Australia and Surf Life Saving NSW in a paid and voluntary capacity.

    Michael Tipton has previously received funding from organisations working in drowning prevention and water safety. He is Chair of the UK National Water Safety Forum, hosted by the Royal Society for the Prevention of Accidents (RoSPA), and a member of Council of the Royal National Lifeboat Institution (RNLI).

    ref. Ice baths are booming in popularity – but they come with health risks – https://theconversation.com/ice-baths-are-booming-in-popularity-but-they-come-with-health-risks-260206

    MIL OSI AnalysisEveningReport.nz

  • MIL-OSI Africa: Committee on Health Welcomes Findings of Section 59 Investigation Panel

    Source: APO


    .

    The Chairperson of the Portfolio Committee on Health, Dr Sibongiseni Dhlomo, has welcomed the findings of the Section 59 investigation panel, which has uncovered systemic racial discrimination in the implementation of fraud, waste and abuse systems by medical schemes and administrators.

    “The report paints a concerning picture of the disproportionate impact that medical schemes’ fraud, waste and abuse systems have had on black healthcare providers,” said Dr Dhlomo. “The statistical evidence presented by the panel’s expert, clearly demonstrates that black providers were significantly more likely to be found guilty of fraud, waste and abuse compared to their non-black counterparts.”

    The panel’s analysis revealed that across the three major schemes investigated – Discovery, GEMS and Medscheme – black providers were between 1.5 to 3.5 times more likely to be identified as guilty of fraud, waste and abuse. In certain disciplines, such as physiotherapy, psychology and social work, the risk ratios for black providers were even higher, reaching up to 12 times more likely to be found guilty.

    “These findings are deeply troubling and point to systemic flaws in the design and implementation of the fraud, waste and abuse systems,” continued Dr Dhlomo. “It is unacceptable that black healthcare providers have been subjected to such blatantly discriminatory treatment, which has undoubtedly had a devastating impact on their livelihoods and the communities they serve,” he said.

    The committee commends the panel for its thorough and independent investigation, and welcomes the recommendations made to the Council for Medical Schemes (CMS) to ensure the ongoing monitoring of the fraud, waste and abuse systems to prevent further discriminatory outcomes.

    Dr Dhlomo stated that he is in discussions with the Minister of Health, Dr Aaron Motsoaledi, about the report. The aim is to ensure that the Minister, the Department of Health, and the entities that the committee oversees and that have been implicated will be invited to provide a briefing to the committee on the findings, outcomes and recommendations presented in the report.

    “We cannot allow such systemic discrimination to continue unchecked, as it undermines the transformation of the healthcare sector and the constitutional right to equality,” said Dr Dhlomo.

    Distributed by APO Group on behalf of Republic of South Africa: The Parliament.

    MIL OSI Africa

  • MIL-OSI Africa: Supporting flood-affected populations in Democratic Republic of Congo to recover

    Source: APO


    .

    Salima, a mother of four, was severely affected by the floods that hit Kinshasa, the capital of the Democratic Republic of the Congo, in April 2025. She had previously fled violence and insecurity in the country’s eastern provinces to seek refuge in Kinshasa “A few days after I arrived, the rains caught us by surprise. We lost everything. The entire neighbourhood was heavily flooded. People had to flee to seek refuge elsewhere.”   

    Many of the flood-affected Kinshasa residents were provided with temporary shelter in Kinkole, a neighbourhood in Kinshasa where the government set up a site. More than 100 families were relocated to the shelters. With ambulances mobilized under the World Health Organization’s (WHO) SURGE system – a mechanism project for public health emergency preparedness and response – many patients, including pregnant women, were transferred promptly to referral health facilities, ensuring timely and appropriate care. 

    “Less than 24 hours after the disaster, we were on the ground for a rapid assessment of the situation,” said Dr Guy Kalambayi, Emergency Preparedness and Response Officer with WHO in the Democratic Republic of the Congo. “We helped set up a care unit with the minimum resources needed to relieve the population. Our responsiveness was greatly appreciated by the communities, both in terms of addressing their immediate needs and safeguarding their health.”

    WHO supported the health authorities to develop public health situation analysis, provide health services to those affected, assess the health needs and provide safe drinking water to the displaced and the households hosting them. 

    By June 2025, more than 5000 people were still living at the Kinkole site, out of the over 10 000 people affected by the floods in the sprawling capital city and its surroundings.

    Over than two months after the devastating floods that affected at least five major cities in the country, the authorities, supported by WHO and partners, continue to assist those affected to recover from the disaster. 

    In total, about 1.5 million people were affected across the country by the floods, which also damaged more than 200 schools, over 100 health centres, as well as houses and markets. WHO provided essential medical supplies, including emergency medical equipment, to cover the health needs of 10 000 people for three months. WHO also supplied four tents for emergency shelter.

    “With access to health services disrupted by the disaster, it is critically important to care for vulnerable groups such as pregnant women, children, the elderly and persons with disabilities or chronic conditions who require regular care,” says Dr Kalmbayi. 

    The authorities launched emergency efforts to repair damaged infrastructure and mobilize teams to coordinate humanitarian assistance. In Kinkole and elsewhere, the government and its partners are taking measures to ensure appropriate and dignified living conditions, providing continuity of health services and care, including vaccination and psychosocial support. 

    “We needed safe shelter, water and food. That’s what we received, not to mention the care we received with free medicines,” says Albertine, a medical student in Kinshasa affected by the disaster. 

    For Dr Emilia Sana, Flood Incident Manager at the Ministry of Public Health, Hygiene and Social Welfare, the coordinated response to the floods “marks a turning point towards a more effective multisectoral framework for our efforts, bringing key ministries together at the highest level.”

    WHO and partners continue to support the government strengthen outbreak prevention measures, including securing the supply of safe drinking water, sanitation and reinforcing of community-based disease surveillance systems.

    “We may have lost all our material possessions, but we are still alive and in good health. That’s what matters,” says Salima.

    The Democratic Republic of the Congo remains vulnerable to climate-linked disasters. Off-season rains in June, for instance, claimed at least 29 lives in three districts of Kinshasa, with more than 500 households affected.

    “One of the key takeaways from this emergency, both in Kinshasa and other provinces, is that there is power in collaboration, particularly in managing potentially epidemic diseases and chronic conditions, thereby ensuring continuity of care. WHO’s support through providing medicines to the affected communities has been invaluable,” says Dr Sana of the Ministry of Public Health, Hygiene and Social Welfare. 

    Distributed by APO Group on behalf of World Health Organization (WHO) – Democratic Republic of Congo.

    MIL OSI Africa

  • MIL-OSI China: 60 Palestinians killed in Israeli attacks across Gaza

    Source: People’s Republic of China – State Council News

    Palestinians mourn over a victim killed in an Israeli airstrike, outside the Al-Shifa Hospital in Gaza City, on July 8, 2025. [Photo/Xinhua]

    At least 60 Palestinians, including six freed prisoners and a paramedic, were killed in Israeli airstrikes and gunfire across Gaza on Tuesday, according to Palestinian sources.

    Six people were killed by Israeli shelling on two tents housing displaced persons in Khan Younis, southern Gaza and the town of al-Zawaidain, central Gaza, Spokesperson for the Civil Defense in Gaza Mahmoud Basal told Xinhua.

    Hamas said in a press statement that the six were prisoners released from Israeli prisons and deported from the West Bank to Gaza.

    West of Gaza City, an Israeli airstrike on a gathering of Palestinians in the al-Rimal neighborhood killed six people, including two children and two women, and an Israeli airstrike on a house in the Tal al-Hawa neighborhood killed four, including an infant, Basal said.

    Five people were killed in an Israeli airstrike on a house in al-Tuffah, east of Gaza City, whereas three were killed when a bomb dropped by an Israeli drone hit a residential area in the al-Zeitoun neighborhood, south of Gaza City, Basal said, adding that two people, including a child, were killed in an Israeli bombing on al-Tuffah and Sheikh Radwan neighborhoods.

    A vehicle bombing in the city of Deir al-Balah, central Gaza, killed two people, Basal added.

    Meanwhile, Nasser Medical Complex reported in a brief press statement that 25 Palestinians were killed since dawn of Tuesday as a result of separate airstrikes on the Al-Mawasi area, west of Khan Younis.

    A paramedic was also killed while performing his duty as a result of Israeli shelling on Al-Mawasi, according to Palestinian medical sources.

    Six Palestinians, including three children, were killed by Israeli army fire near a U.S.-backed aid distribution center in north of Rafah, southern Gaza, said the sources.

    There was no immediate comment from the Israeli side on these incidents.

    Since Israel resumed its military campaign in Gaza on March 18, at least 7,013 Palestinians have been killed and 24,838 others injured, bringing the overall death toll in Gaza since the conflict began in October 2023 to 57,575, with a total of 136,879 people injured, according to data released Tuesday by health authorities in Gaza. 

    MIL OSI China News

  • MIL-OSI China: 60 Palestinians killed in Israeli attacks across Gaza

    Source: People’s Republic of China – State Council News

    Palestinians mourn over a victim killed in an Israeli airstrike, outside the Al-Shifa Hospital in Gaza City, on July 8, 2025. [Photo/Xinhua]

    At least 60 Palestinians, including six freed prisoners and a paramedic, were killed in Israeli airstrikes and gunfire across Gaza on Tuesday, according to Palestinian sources.

    Six people were killed by Israeli shelling on two tents housing displaced persons in Khan Younis, southern Gaza and the town of al-Zawaidain, central Gaza, Spokesperson for the Civil Defense in Gaza Mahmoud Basal told Xinhua.

    Hamas said in a press statement that the six were prisoners released from Israeli prisons and deported from the West Bank to Gaza.

    West of Gaza City, an Israeli airstrike on a gathering of Palestinians in the al-Rimal neighborhood killed six people, including two children and two women, and an Israeli airstrike on a house in the Tal al-Hawa neighborhood killed four, including an infant, Basal said.

    Five people were killed in an Israeli airstrike on a house in al-Tuffah, east of Gaza City, whereas three were killed when a bomb dropped by an Israeli drone hit a residential area in the al-Zeitoun neighborhood, south of Gaza City, Basal said, adding that two people, including a child, were killed in an Israeli bombing on al-Tuffah and Sheikh Radwan neighborhoods.

    A vehicle bombing in the city of Deir al-Balah, central Gaza, killed two people, Basal added.

    Meanwhile, Nasser Medical Complex reported in a brief press statement that 25 Palestinians were killed since dawn of Tuesday as a result of separate airstrikes on the Al-Mawasi area, west of Khan Younis.

    A paramedic was also killed while performing his duty as a result of Israeli shelling on Al-Mawasi, according to Palestinian medical sources.

    Six Palestinians, including three children, were killed by Israeli army fire near a U.S.-backed aid distribution center in north of Rafah, southern Gaza, said the sources.

    There was no immediate comment from the Israeli side on these incidents.

    Since Israel resumed its military campaign in Gaza on March 18, at least 7,013 Palestinians have been killed and 24,838 others injured, bringing the overall death toll in Gaza since the conflict began in October 2023 to 57,575, with a total of 136,879 people injured, according to data released Tuesday by health authorities in Gaza. 

    MIL OSI China News

  • MIL-OSI Asia-Pac: Import of poultry meat and products from areas in Korea suspended

    Source: Hong Kong Government special administrative region

    The Centre for Food Safety (CFS) of the Food and Environmental Hygiene Department announced today (July 8) that in view of a notification from the World Organisation for Animal Health (WOAH) about outbreaks of highly pathogenic H5N1 avian influenza in Gimhae-si of Gyeongsangnam-do Province and Gangjin-gun of Jeollanam-do Province in Korea, the CFS has instructed the trade to suspend the import of poultry meat and products (including poultry eggs) from the above-mentioned areas with immediate effect to protect public health in Hong Kong.

    A CFS spokesman said that according to the Census and Statistics Department, Hong Kong imported about 60 tonnes of frozen poultry meat and about 5.33 million poultry eggs from Korea in the first three months of this year.

    “The CFS has contacted the Korean authority over the issue and will closely monitor information issued by the WOAH and the relevant authorities on the avian influenza outbreaks. Appropriate action will be taken in response to the development of the situation,” the spokesman said.

    MIL OSI Asia Pacific News

  • MIL-Evening Report: Can’t fill your ADHD script? Here’s why, and what to do while the shortage persists

    Source: The Conversation (Au and NZ) – By Jack Janetzki, Lecturer in Pharmacy and Pharmacology, University of South Australia

    Attention-deficit hyperactivity disorder (ADHD) diagnoses are rising across Australia.

    But after finally getting a diagnosis, many people are discovering the medicine they’ve been prescribed isn’t available at the pharmacy.

    Australia faces a nation-wide shortage of methylphenidate (sold as Concerta and Ritalin).

    What does it mean for people with ADHD?

    ADHD medication shortages have persisted since 2023, with shortages of lisdexamfetamine (Vyvanse), and are now affecting more people.

    Many people with ADHD have to call multiple pharmacies to find their medication. They might be put on waiting lists to access their prescribed medications, or have to contact their doctor or their child’s doctor to get a new script for a different medication.

    Some people with ADHD are switching between strengths or changing to different medicines. This can mean starting again with slow dose changes, and can result in poor symptom control and more side effects.

    Some people have had to skip doses or go without medicine altogether, making it hard to concentrate, stay organised and manage emotions.

    Shortages can also increase inequality. People in rural areas with fewer pharmacies, for example, have more difficulty accessing these medications.

    And people with fewer financial resources are less able to access alternative medications that aren’t subsidised.

    Increasing access to diagnosis and treatment

    Around 8% of children and 2.5% of adults in Australia have ADHD. It makes it hard to focus, sit still, and/or control impulses. For many, medication helps manage these symptoms.

    Diagnosis has often involved seeing a specialist such as psychiatrist or paediatrician.

    But from September, GPs in New South Wales will be able to continue ADHD prescriptions without needing specialist approval. In 2026, GPs in South Australia and Western Australia will be able to diagnose ADHD and start treatment.

    However, ongoing shortages may still stop people from getting the medicine they need.

    Why are these medicines running out?

    These shortages are largely due to manufacturing issues – including problems sourcing raw ingredients and production quotas in the United States.

    When one brand runs out, it puts pressure on other brands. This creates a domino effect across the supply chain.

    There is also increasing demand.

    In 2022-2023 almost 470,000 Australians were prescribed ADHD medications. That’s four times the number from nine years earlier.

    From January 2024 to May 2025, the number of prescriptions filled increased further, by 60% for dexamfetamine, 88% for methylphenidate and 140% for lisdexamfetamine.

    Scripts filled for ADHD stimulants from January 2024 to May 2025.
    CC BY

    Shortages of several strengths and brands of menthylphenidate (Concerta and Ritalin) and are expected to continue into late 2025. Both the long-acting and short-acting types are affected.

    Pharmacies can’t always help

    Stimulants to treat ADHD are tightly controlled. Pharmacies can only supply one-month of medicine at a time.

    In some states such as NSW, paper prescriptions for tightly controlled medicines must be filled at the same pharmacy each time. So patients have not been able to get their medicine elsewhere even if it’s in stock.

    In response to the methylphenidate shortages, NSW Health has allowed pharmacies to transfer paper prescriptions to other pharmacists that have stock available. This change is temporary but helpful.

    This rule is different in other states such as Victoria and South Australia, where people are able to visit or call other pharmacies to see if they have stock.

    However, ideally a patient will be able to build a rapport with one main pharmacy – and the pharmacy will know exactly how many regular patients they need to get stock for.

    What are regulators doing about it?

    The national medicines regulator, the Therapeutic Goods Administration (TGA) has set up a group called the Medicine Shortage Action Groups to respond to the methylphenidate shortage.

    This group includes members from health professional groups and peak bodies. It will give advice to health professionals and are creating resources for patients, families and schools about the shortages and how to reduce disruptions to their or their child’s treatment.

    The TGA has also recently approved the temporary use of some methylphenidate brands from overseas.

    Some of these are now listed on the Pharmaceutical Benefits Scheme, which means they are available at a subsidised price.

    The body representing physicians, the Royal Australasian College of Physicians, has called for early warnings about shortages. That way, doctors can help patients change to alternatives before it’s too late.

    What can you do if you can’t get a script filled?

    If you’re finding it hard to get your ADHD medicine:

    • talk to your pharmacist. They may be able to order an overseas-registered alternative or suggest a different brand

    • speak with your GP, psychiatrist or your child’s paediatrician. They might adjust your or your child’s dose or suggest a different medication for their ADHD. This might mean changing to another stimulant that is available in a short- or long-acting formulation or by changing to a medicine for ADHD that is not a stimulant. Ask your physician to contact the pharmacy to see what they have in stock while you’re at your appointment

    • check the TGA’s Medicine Shortage Reports Database for updates on when the medicine might become available.

    If you’re calling around to find stock:

    • call mid-morning to see if they’ve got stock. Pharmacies are generally less busy after the morning rush

    • say exactly what medicine, strength and brand you are looking for. If you don’t mind which brand be sure to tell the pharmacist

    • keep a list of pharmacies so you don’t double up

    • if you live in a rural area and find that a pharmacy in a nearby town has stock, ask if they can courier the medication to you.

    Jack Janetzki works for Pharmaceutical Defence Limited and The Barossa Pharmacist in the Mall (Nuriootpa, South Australia). He is a member of Pharmaceutical Defence Limited, the Australasian Pharmaceutical Science Association, the Pharmaceutical Society of Australia and the Observational Health Data Science Informatics network.

    Lisa Kalisch Ellett is president of the Australasian Pharmaceutical Science Association and a member of the Pharmaceutical Society of Australia.

    ref. Can’t fill your ADHD script? Here’s why, and what to do while the shortage persists – https://theconversation.com/cant-fill-your-adhd-script-heres-why-and-what-to-do-while-the-shortage-persists-259911

    MIL OSI AnalysisEveningReport.nz

  • MIL-OSI NGOs: Climate crisis tripled death toll of Europe’s latest heatwave: Greenpeace calls for polluters to pay

    Source: Greenpeace Statement –

    Amsterdam – Responding to a rapid study by scientists at Imperial College London and the London School of Hygiene & Tropical Medicine that found that the number of heat-related deaths across 12 European cities tripled due to the climate crisis in the 10 day period between 23 June and 2 July, as well as to preliminary data published by the Copernicus Climate Change Service that June 2025 was the hottest ever June for Western Europe and the third-warmest June globally.[1][2]

    Ian Duff, Head of Greenpeace International’s Stop Drilling Start Paying campaign said: “It is society’s most vulnerable – in Milan, Barcelona, Paris, London and elsewhere – who suffer most in the midst of record temperatures. Europe’s dependence and soft hand on oil and gas corporations who are fueling this extreme heat is giving a death blow to our parents and grandparents.” 

    “This heatwave comes when public finances are already stretched and it is only fair that those most responsible are made to pay. For European cities to become safe spaces for society’s most vulnerable, polluters like Shell and TotalEnergies must face fines and taxes to pay for soaring climate and health costs.”

    Beyond excess mortality, the latest heatwave in Europe resulted in restrictions on outdoor work hours in Italy, the closure of more than 2,200 schools in France, and wildfires breaking out in Greece, Spain, and Turkey.

    Eight out of 10 people support taxing oil and gas corporations to pay for climate damages, according to a global survey commissioned by Greenpeace International and Oxfam International. The two organisations are part of the Polluters Pay Pact, a global alliance of over 170,000 people, including first responders like firefighters, humanitarian groups and political leaders. It demands that governments around the world make oil, coal and gas corporations pay their fair share for the damages they cause

    ENDS

    Notes:

    [1] “Climate change tripled heatwave death toll in European cities during last week’s heatwave” – Imperial College London and the London School of Hygiene & Tropical Medicine

    [2] “Third-warmest June globally – Heatwaves in Europe amid temperature extremes across both hemispheres” – Copernicus 

    Contact:

    Tal Harris, Global Media Lead – Greenpeace International’s Stop Drilling Start Paying campaign, +41-782530550, [email protected] 

    Greenpeace International Press Desk: [email protected], +31 (0) 20 718 2470 (available 24 hours)

    MIL OSI NGO

  • MIL-Evening Report: Medicinal cannabis is big business. But the latest clampdown won’t curb unsafe prescribing

    Source: The Conversation (Au and NZ) – By Carmen Lim, NHMRC Emerging Leadership Fellow, National Centre for Youth Substance Use Research, The University of Queensland

    Nuva Frames/Shutterstock

    Australia’s key regulator of health professionals has announced it’s clamping down on unsafe prescribing of medicinal cannabis in the wake of surging patient demand.

    The Australian Health Practitioner Regulation Agency, known as Ahpra, today warned health professionals they would need to put patients’ wellbeing ahead of profits.

    Among its concerns were aggressive marketing strategies by clinics prescribing medicinal cannabis, and consultations lasting between a few seconds and a few minutes, before prescribing.

    Such concerns have led to eight practitioners issuing more than 10,000 scripts in a six-month window, and one who appeared to have issued more than 17,000 scripts.

    Ahpra’s other concerns include reports of patients with psychosis after taking medicinal cannabis, prescribing high doses, and prescribing to family members or people under 18.

    However, overservicing, inappropriate prescribing and the health issues that can arise are issues we’ve known about for years.

    Our research, for example, looked at multiple websites that offered medicinal cannabis in Australia. We found widespread examples of aggressive and misleading marketing. Some clinics breached regulatory guidelines. Others bent the rules.

    Yet Ahpra’s latest announcement doesn’t tighten existing prescribing or marketing rules for medicinal cannabis. It just reminds doctors, nurse practitioners and pharmacists what the rules are.

    What is the regulator concerned about?

    According to the 2022–23 National Drug Strategy Household Survey, 3% of Australians aged 14 or over had used cannabis for medical purposes in the previous 12 months, equating to around 700,000 people.

    Australians spent more than A$400 million on medicinal cannabis products in the first half of 2024 alone.

    But Ahpra is concerned too many health practitioners are prescribing medicinal cannabis when a patient requests it, rather than whether this is the right product for them.

    It suggests too few practitioners are assessing patients thoroughly, formulating and implementing a management plan, facilitating coordination and continuity of care, maintaining medical records, recommending treatments only where there is an identified therapeutic need, and ensuring medicinal cannabis is not a first-line treatment.

    So Ahpra says it will investigate practitioners with high rates of prescribing any scheduled medicine, including medicinal cannabis, even if it has not received a complaint.

    We found lots of aggressive marketing

    Medicinal cannabis has been legally available in Australia since 2016. This means doctors can prescribe it for any medical condition when other approved treatments have not worked. Now patients can be prescribed medicinal cannabis as a capsule, oil or dried flower, for example, often via a website.

    But when we analysing the websites of 54 private medicinal cannabis clinics in Australia, an alarming picture emerged.

    We found multiple examples of websites that breached marketing rules, or skirted around them. This included making unsubstantiated health claims about the products they offered, such as they could treat anxiety, depression, or other mental health symptoms.

    Websites often allowed people to assess if medicinal cannabis was for them. This self-assessment may mislead people into believing they would benefit from it, inadvertently “coaching” them on which medical conditions might warrant a prescription.

    Other marketing tactics we found included promises of same-day or after-hours delivery, no GP referrals required, discounted consultation fees, and
    targeted advertisements on social media.

    What we’d like to see

    Ahpra’s aim of safer prescribing of medicinal cannabis is welcome. But by merely repeating the rules, rather than tightening them, this doesn’t go far enough. So Ahpra has missed out on a real opportunity to safeguard patients’ health.

    For instance, we’d like to see greater emphasis on banning targeted advertisements on social media for medicinal cannabis. In a study that we’ve submitted for publication, we found this a particular concern.

    We found many private clinics are using ads to reach young people, including those as young as 18. One company ran more than 170 active ads this month alone across Facebook, Instagram and Threads.

    Ads we’ve seen include cryptic messaging, such as “we can’t shout about it, but our patients are smiling”, paired with bright colours and wellness-themed imagery.

    One pairs an Australian sports celebrity with the tagline “move differently!” and the name of the product.

    Another one promises “real doctors, real care” and “fast approvals & express delivery”, with consultations at $19.

    While these ads do not mention medicinal cannabis directly, the messaging is clearly designed to spark curiosity and build brand recognition, especially among younger audiences.

    We’d also like to see Ahpra:

    • broaden its focus beyond prescribing patterns to include digital marketing and advertising practices that target young people

    • provide clear guidelines to medicinal cannabis clinics and prescribers on acceptable promotional practices

    • support stronger consequences for repeat offenders, including prescribers who continue to engage in misleading advertising after being sanctioned.

    Carmen Lim receives funding from the National Medical Health Research Council (2024-2028). She has not received any funding from the alcohol, cannabis, pharmaceutical, tobacco or vaping industries.

    ref. Medicinal cannabis is big business. But the latest clampdown won’t curb unsafe prescribing – https://theconversation.com/medicinal-cannabis-is-big-business-but-the-latest-clampdown-wont-curb-unsafe-prescribing-260803

    MIL OSI AnalysisEveningReport.nz

  • MIL-OSI United Kingdom: expert reaction to ‘rapid heat death attribution study’ as released by Imperial’s Grantham Institute

    Source: United Kingdom – Executive Government & Departments

    Scientists comment on a heat-related death attribution study released by the Grantham Institute at Imperial College London. 

    Dr Akshay Deoras, Research Scientist at the University of Reading, said:

    “Robust techniques used in this study leave no doubt that climate change is already a deadly force in Europe. Think of the Earth like an oven. In the past, heatwaves were like turning the oven up for a short burst. But with climate change, it is as if we have permanently set the oven to a higher temperature. It takes much less to reach dangerous levels of heat that can be fatal.

    “The June 2025 heatwave across parts of Europe and the UK was not simply a natural disaster—it was supercharged by fossil fuel emissions, costing countless lives in major cities. Heatwaves are now more frequent and intense because our planet’s baseline temperature is higher due to greenhouse gas emissions. Without urgent action to reduce fossil fuel emissions, these extreme heat events will become even more common and severe, putting greater pressure on health systems, disrupting daily life, and threatening the safety of communities across Europe.”

    Prof Richard Allan, Professor of Climate Science at the University of Reading, said:

    “A warming climate sure as hell makes heatwaves worse.  This forensic analysis combining observations, simulations and health data has shown how much more dangerous the recent European heatwave was across several cities with the higher levels of greenhouse gases in the atmosphere.  

    “Even without these rapid attribution studies, it is blindingly obvious from the multiple lines of evidence that when weather conditions generate heatwaves, they are more intense, meaning that moderate heat becomes dangerous and record heat becomes unprecedented. The other side of the coin is that as one part of the globe bakes and burns, another region can suffer intense rainfall and catastrophic flooding as a warmer, thirstier atmosphere saps the moisture from one region and winds blow this excess moisture into storm systems elsewhere.  

    “Communities need to adapt to an increasingly dangerous world through more resilient infrastructure and improved warning systems, yet it is only with rapid and massive cuts in greenhouse gases through collaboration across all sectors of society that worsening of weather extremes can be reined in.”

     

    Dr Chloe Brimicombe, climate scientist at the Royal Meteorological Society, said:

    “The study quickly shows how 65% of heatwave deaths in the last European heatwave can be linked to human-induced climate change in different cities. This is important because it shows that reducing emissions, which would stop an increase in heatwaves, could save lives. 

    “We are facing more heatwaves this summer across Europe, with many regions also moving towards drought which increases heat and risk of wildfires increase too. We could see more deaths in heatwaves this summer. Research like this is important and being used more in climate litigation cases where groups take countries and companies to court over climate change. 

    “It’s possible this study has even underestimated deaths slightly because it’s not taking into account the built environment and we know that often poorer parts of cities are more impacted because they are less “green” which means they heat up even more. 

    “The results are a model summary of an increase in deaths over populations of cities during a heat period. But in reality the realisation of the risk of cardiac arrest is different to someone drowning. And that is why it’s important to issue heat warnings to everyone because there are a lot of different ways someone dies during a heatwave. 

    “We need to talk about other heatwave impacts like pressure on transport, energy and food supplies. And we quickly need to think about how heat impacts economies as part of loss and damage. We also need to consider the rise in people attending hospital. We don’t really know enough about how heat impacts breastfeeding women and newborns, for example. 

    “Heatwaves silently pressure our society. For some individuals this is now from before birth to the day they die.”

    ‘Climate change tripled heat-related deaths in early summer European Heatwave’ by Ben Clarke et al. is an unpublished ‘rapid heat death attribution study’ led by scientists at Imperial College London and the London School of Hygiene & Tropical Medicine.  The embargo lifted at 5am UK time on Wednesday 9 July 2025.

    Declared interests

    Richard Allan: “No conflicting interests”

    Chloe Brimicombe: “No disclosures”

    For all other experts, no reply for our request for DOIs was received. 

    MIL OSI United Kingdom

  • MIL-OSI Russia: Four killed, 27 injured in fire at Cairo TV building

    Translation. Region: Russian Federal

    Source: People’s Republic of China in Russian – People’s Republic of China in Russian –

    An important disclaimer is at the bottom of this article.

    Source: People’s Republic of China – State Council News

    CAIRO, July 9 (Xinhua) — At least four people were killed and 27 others were injured in a major fire that broke out at the Telecom Egypt building in central Cairo on Monday, Egypt’s Health Ministry said on Tuesday.

    The injured were taken to nearby hospitals, while several others were treated at the scene for smoke inhalation, the ministry said in a statement.

    A fire that started on Monday afternoon at a key telecommunications facility owned by Telecom Egypt in Cairo’s Ramses district has caused temporary disruptions to telephone and internet service in parts of the capital and other regions.

    Egypt’s Communications and Information Technology Minister Amr Talaat said on Tuesday that services would be gradually restored within 24 hours.

    Meanwhile, Egypt’s Civil Aviation Ministry announced that flights at Cairo International Airport had resumed in full following overnight delays caused by communication disruptions.

    “All affected flights have departed and operations at all Cairo airport terminals have returned to normal,” the ministry said in a statement.

    A security source told the official MENA news agency that a preliminary investigation suggests the fire was caused by a short circuit, noting that forensic lab experts will collect evidence from the scene to determine the exact cause. –0–

    Please note: This information is raw content obtained directly from the source of the information. It is an accurate report of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.

    .

    MIL OSI Russia News